Expression	O
of	O
mRNA	B-RNA
for	O
the	O
GATA-binding	B-protein
proteins	I-protein
in	O
human	B-cell_type
eosinophils	I-cell_type
and	O
basophils	B-cell_type
:	O
potential	O
role	O
in	O
gene	O
transcription	O
.	O

The	O
expression	O
of	O
the	O
hematopoietic	B-protein
transcription	I-protein
factors	I-protein
GATA-1	B-protein
,	O
GATA-2	B-protein
,	O
and	O
GATA-3	B-protein
was	O
studied	O
in	O
eosinophils	B-cell_type
and	O
basophils	B-cell_type
.	O

Eosinophils	B-cell_type
express	O
mRNA	B-RNA
for	O
GATA-1	B-protein
,	O
GATA-2	B-protein
,	O
and	O
GATA-3	B-protein
.	O

Basophils	B-cell_type
express	O
GATA-2	B-protein
and	O
GATA-3	B-protein
.	O

Treatment	O
of	O
HL-60	B-cell_line
eosinophilic	I-cell_line
sublines	I-cell_line
with	O
either	O
interleukin-5	B-protein
or	O
butyric	O
acid	O
increased	O
the	O
expression	O
of	O
GATA-1	B-RNA
mRNA	I-RNA
concomitant	O
with	O
the	O
expression	O
of	O
eosinophil-specific	B-DNA
genes	I-DNA
,	O
whereas	O
levels	O
of	O
GATA-2	B-RNA
mRNA	I-RNA
remained	O
relatively	O
constant	O
.	O

The	O
presence	O
of	O
mRNA	B-RNA
for	O
these	O
proteins	O
in	O
eosinophils	B-cell_type
and	O
basophils	B-cell_type
suggests	O
that	O
gene	O
transcription	O
in	O
these	O
lineages	O
may	O
be	O
regulated	O
by	O
GATA-binding	B-protein
proteins	I-protein
.	O

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

Expression	NULL
of	NULL
mRNA	NULL
for	NULL
the	NULL
GATA-Binding	NULL
Proteins	NULL
in	NULL
Human	NULL
Eosinophils	NULL
and	NULL
Basophils	NULL
:	NULL
Potential	NULL
Role	NULL
in	NULL
Gene	NULL
Transcription	NULL
By	NULL
Leonard	NULL
I.	NULL
Zon	NULL
,	NULL
Yuji	NULL
Yamaguchi	NULL
,	NULL
Karen	NULL
Yee	NULL
,	NULL
Edward	NULL
A.	NULL
Albee	NULL
,	NULL
Akira	NULL
Kimura	NULL
,	NULL
Joshua	NULL
C.	NULL
Bennett	NULL
,	NULL
Stuart	NULL
H.	NULL
Orkin	NULL
,	NULL
and	NULL
Steven	NULL
J.	NULL
Ackerman	NULL
The	NULL
expression	NULL
of	NULL
the	NULL
hematopoietic	NULL
transcription	NULL
factors	NULL
GATA-1	NULL
,	NULL
GATA-2	NULL
,	NULL
and	NULL
GATA-3	NULL
was	NULL
studied	NULL
in	NULL
eosinophils	NULL
and	NULL
basophils	NULL
.	NULL

Eosinophils	NULL
express	NULL
mRNA	NULL
for	NULL
GATA-1	NULL
,	NULL
GATA-2	NULL
,	NULL
and	NULL
GATA-3	NULL
.	NULL

Basophils	NULL
express	NULL
GATA-2	NULL
and	NULL
GATA-3	NULL
.	NULL

Treatment	NULL
of	NULL
HL-60	NULL
eosinophilic	NULL
sublines	NULL
with	NULL
either	NULL
interleukin-5	NULL
or	NULL
butyric	NULL
acid	NULL
increased	NULL
the	NULL
expression	NULL
of	NULL
GATA-1	NULL
mRNA	NULL
concomitant	NULL
with	NULL
the	NULL
expression	NULL
of	NULL
OSINOPHILS	NULL
and	NULL
basophils	NULL
are	NULL
terminally	NULL
differentiated	NULL
cells	NULL
that	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
mediate	NULL
allergic	NULL
and	NULL
related	NULL
immune	NULL
responses	NULL
and	NULL
to	NULL
act	NULL
as	NULL
effector	NULL
cells	NULL
in	NULL
immunity	NULL
to	NULL
parasitic	NULL
infections	NULL
.	NULL
``	NULL

Despite	NULL
their	NULL
hematopoietic	NULL
relationships	NULL
,	NULL
``	NULL
overlapping	NULL
responses	NULL
to	NULL
certain	NULL
cytokines	NULL
(	NULL
eg	NULL
,	NULL
interleukin-3	NULL
[	NULL
IL-3	NULL
]	NULL
,	NULL
IL-5	NULL
,	NULL
and	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
[	NULL
GM-CSF	NULL
]	NULL
)	NULL
,	NULL
and	NULL
possible	NULL
functional	NULL
interactions	NULL
,	NULL
``	NULL
eosinophils	NULL
and	NULL
basophils	NULL
each	NULL
express	NULL
a	NULL
distinct	NULL
cell-specific	NULL
program	NULL
.	NULL

Eosinophils	NULL
contain	NULL
a	NULL
variety	NULL
of	NULL
unique	NULL
cationic	NULL
protein	NULL
mediators	NULL
of	NULL
inflammation	NULL
in	NULL
their	NULL
primary	NULL
and	NULL
secondary	NULL
(	NULL
specific	NULL
)	NULL
granules	NULL
.	NULL

``	NULL
*	NULL
These	NULL
mediators	NULL
include	NULL
eosinophil	NULL
peroxidase	NULL
(	NULL
EPO	NULL
)	NULL
,	NULL
eosinophil	NULL
major	NULL
basic	NULL
protein	NULL
(	NULL
MBP	NULL
)	NULL
,	NULL
eosinophil	NULL
cationic	NULL
protein	NULL
(	NULL
ECP	NULL
)	NULL
,	NULL
and	NULL
eosinophil-derived	NULL
neurotoxin	NULL
(	NULL
EDN	NULL
)	NULL
(	NULL
mRNA	NULL
for	NULL
EDN	NULL
is	NULL
also	NULL
expressed	NULL
in	NULL
neutrophils	NULL
,	NULL
and	NULL
is	NULL
identical	NULL
to	NULL
liver	NULL
ribonuclease	NULL
)	NULL
.	NULL
``	NULL

The	NULL
basophil	NULL
program	NULL
has	NULL
not	NULL
been	NULL
as	NULL
well	NULL
defined	NULL
as	NULL
the	NULL
eosinophil	NULL
program	NULL
.	NULL

One	NULL
specific	NULL
marker	NULL
of	NULL
the	NULL
basophil	NULL
lineage	NULL
,	NULL
the	NULL
Bsp-1	NULL
cell-surface	NULL
antigen	NULL
,	NULL
``	NULL
has	NULL
been	NULL
identified	NULL
.	NULL

Basophils	NULL
have	NULL
also	NULL
been	NULL
shown	NULL
to	NULL
possess	NULL
a	NULL
unique	NULL
phenotype	NULL
,	NULL
including	NULL
certain	NULL
activation-linked	NULL
surface	NULL
membrane	NULL
pro-teins	NULL
.	NULL
``	NULL

Interestingly	NULL
,	NULL
Charcot-Leyden	NULL
crystal	NULL
(	NULL
CLC	NULL
)	NULL
pro-tein	NULL
,	NULL
'*	NULL
a	NULL
lysophospholipase	NULL
(	NULL
EC	NULL
3.1.1.5	NULL
)	NULL
,	NULL
is	NULL
uniquely	NULL
expressed	NULL
in	NULL
both	NULL
eosinophils	NULL
and	NULL
basophils'*	NULL
``	NULL
``	NULL
in	NULL
comparable	NULL
amounts	NULL
.	NULL
``	NULL

Hematopoietic	NULL
differentiation	NULL
is	NULL
regulated	NULL
in	NULL
part	NULL
by	NULL
ex	NULL
From	NULL
the	NULL
Division	NULL
of	NULL
Hematology-Oncology	NULL
,	NULL
The	NULL
Children	NULL
's	NULL
Hospital	NULL
,	NULL
Dana-Farber	NULL
Cancer	NULL
Institute	NULL
,	NULL
Department	NULL
of	NULL
Pediatrics	NULL
,	NULL
and	NULL
the	NULL
Infectious	NULL
Disease	NULL
Division	NULL
,	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
Beth	NULL
Israel	NULL
Hospital	NULL
,	NULL
Harvard	NULL
Medical	NULL
School	NULL
;	NULL
and	NULL
the	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
.	NULL

Submitted	NULL
November	NULL
19	NULL
,	NULL
1991	NULL
;	NULL
accepted	NULL
January	NULL
27	NULL
,	NULL
1993	NULL
.	NULL

Supported	NULL
in	NULL
part	NULL
by	NULL
Physician-Scientist	NULL
Award	NULL
NIH-HLO2347	NULL
and	NULL
a	NULL
grant	NULL
from	NULL
the	NULL
Charles	NULL
H.	NULL
Hood	NULL
Foundation	NULL
(	NULL
LLZ	NULL
.	NULL
)	NULL

;	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grants	NULL
No	NULL
.	NULL

A125230	NULL
,	NULL
A122660	NULL
,	NULL
and	NULL
A133043	NULL
(	NULL
S.J	NULL
.	NULL

A	NULL
.	NULL
)	NULL

;	NULL
and	NULL
Sandoz	NULL
Pharmaceuticals	NULL
Japan	NULL
,	NULL
Ltd	NULL
(	NULL
Y.Y	NULL
.	NULL
)	NULL

.	NULL

S.H.0	NULL
.	NULL

is	NULL
an	NULL
Investigator	NULL
of	NULL
the	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
.	NULL

Address	NULL
reprint	NULL
requests	NULL
to	NULL
Leonard	NULL
I.	NULL
Zon	NULL
,	NULL
MD	NULL
,	NULL
Division	NULL
of	NULL
Hematology	NULL
,	NULL
Children	NULL
's	NULL
Hospital	NULL
,	NULL
300	NULL
Longwood	NULL
Ave	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
02115	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

©	NULL
1993	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

0006-497	NULL
1/93/81	NULL
1	NULL
2-00208	NULL
$	NULL
3.00/0	NULL
3234	NULL
eosinophil-specific	NULL
genes	NULL
,	NULL
whereas	NULL
levels	NULL
of	NULL
GATA-2	NULL
mRNA	NULL
remained	NULL
relatively	NULL
constant	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
mRNA	NULL
for	NULL
these	NULL
proteins	NULL
in	NULL
eosinophils	NULL
and	NULL
basophils	NULL
suggests	NULL
that	NULL
gene	NULL
transcription	NULL
in	NULL
these	NULL
lineages	NULL
may	NULL
be	NULL
regulated	NULL
by	NULL
GATA-binding	NULL
proteins	NULL
.	NULL

©	NULL
1993	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

tracellular	NULL
processes	NULL
,	NULL
such	NULL
as	NULL
activation	NULL
of	NULL
specific	NULL
cell-surface	NULL
receptors	NULL
by	NULL
lineage-restricted	NULL
cytokines	NULL
.	NULL
``	NULL

Whereas	NULL
GM-CSF	NULL
and	NULL
IL-3	NULL
each	NULL
allow	NULL
proliferation	NULL
of	NULL
eosinophil	NULL
progenitors	NULL
,	NULL
IL-5	NULL
is	NULL
more	NULL
specifically	NULL
involved	NULL
in	NULL
their	NULL
differentiation	NULL
and	NULL
functional	NULL
activation	NULL
.	NULL
``	NULL

''	NULL
'	NULL
It	NULL
has	NULL
been	NULL
recently	NULL
shown	NULL
that	NULL
the	NULL
8	NULL
subunit	NULL
of	NULL
the	NULL
IL-5	NULL
,	NULL
GM-CSF	NULL
,	NULL
and	NULL
IL-3	NULL
cytokine	NULL
receptor	NULL
complexes	NULL
is	NULL
shared	NULL
and	NULL
that	NULL
these	NULL
receptors	NULL
show	NULL
some	NULL
functional	NULL
cross-reactivity	NULL
.	NULL
``	NULL

Plating	NULL
of	NULL
bone	NULL
marrow	NULL
cells	NULL
in	NULL
semisolid	NULL
media	NULL
containing	NULL
IL-5	NULL
leads	NULL
to	NULL
the	NULL
formation	NULL
of	NULL
colonies	NULL
containing	NULL
eosinophils	NULL
.	NULL
``	NULL

''	NULL
In	NULL
addition	NULL
,	NULL
transgenic	NULL
mice	NULL
that	NULL
constitutively	NULL
express	NULL
IL-5	NULL
have	NULL
extremely	NULL
high	NULL
numbers	NULL
of	NULL
eosinophils	NULL
.	NULL

``	NULL
*	NULL
``	NULL
°	NULL
IL-3	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
induce	NULL
basophil	NULL
proliferation	NULL
``	NULL
and	NULL
differen-tiation	NULL
,	NULL
``	NULL
yet	NULL
cytokines	NULL
regulating	NULL
basophil	NULL
differentiation	NULL
have	NULL
not	NULL
been	NULL
well	NULL
characterized	NULL
.	NULL
``	NULL

HL-60	NULL
sublines	NULL
have	NULL
been	NULL
used	NULL
as	NULL
models	NULL
of	NULL
eosinophil	NULL
and	NULL
basophil	NULL
differentiation	NULL
.	NULL
``	NULL

''	NULL
``	NULL
``	NULL
We	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
IL-5	NULL
treatment	NULL
of	NULL
the	NULL
HL-60	NULL
(	NULL
3+C-5	NULL
)	NULL
cell	NULL
line*	NULL
results	NULL
in	NULL
eosinophil-specific	NULL
gene	NULL
expression	NULL
defined	NULL
by	NULL
the	NULL
expression	NULL
of	NULL
ECP	NULL
,	NULL
EDN	NULL
,	NULL
and	NULL
CLC	NULL
protein	NULL
.	NULL

>	NULL
>	NULL
>	NULL
``	NULL
°	NULL
In	NULL
addition	NULL
,	NULL
butyrate	NULL
treatment	NULL
of	NULL
the	NULL
HL-60	NULL
(	NULL
C15	NULL
)	NULL
subline	NULL
``	NULL
similarly	NULL
induces	NULL
the	NULL
expression	NULL
of	NULL
mRNA	NULL
for	NULL
all	NULL
the	NULL
eosinophil	NULL
granule-associated	NULL
proteins	NULL
(	NULL
Y.	NULL
Yamaguchi	NULL
,	NULL
D.	NULL
Tenen	NULL
,	NULL
S.	NULL
J.	NULL
Ackerman	NULL
,	NULL
et	NULL
al	NULL
,	NULL
manuscript	NULL
in	NULL
preparation	NULL
)	NULL
,	NULL
the	NULL
synthesis	NULL
of	NULL
a	NULL
variety	NULL
of	NULL
eosinophil-associated	NULL
enzymes	NULL
,	NULL
and	NULL
also	NULL
results	NULL
in	NULL
a	NULL
phenotypic	NULL
increase	NULL
in	NULL
the	NULL
numbers	NULL
of	NULL
granules	NULL
.	NULL

``	NULL
>	NULL
Although	NULL
the	NULL
cytokine-directed	NULL
regulation	NULL
of	NULL
eosinophil	NULL
and	NULL
basophil-specific	NULL
gene	NULL
expression	NULL
has	NULL
been	NULL
studied	NULL
as	NULL
noted	NULL
above	NULL
,	NULL
the	NULL
role	NULL
of	NULL
transcription	NULL
factors	NULL
in	NULL
these	NULL
hematopoietic	NULL
regulatory	NULL
processes	NULL
has	NULL
not	NULL
been	NULL
investigated	NULL
.	NULL

GATA-binding	NULL
proteins	NULL
have	NULL
previously	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
important	NULL
regulators	NULL
of	NULL
hematopoietic-specific	NULL
transcrip-tion	NULL
.	NULL
``	NULL

GATA-1	NULL
was	NULL
originally	NULL
isolated	NULL
for	NULL
its	NULL
ability	NULL
to	NULL
bind	NULL
a	NULL
core	NULL
GATA	NULL
site	NULL
present	NULL
in	NULL
the	NULL
promoters	NULL
and	NULL
enhancers	NULL
of	NULL
many	NULL
erythroid	NULL
genes	NULL
,	NULL
*	NULL
``	NULL
~*	NULL
including	NULL
heme	NULL
biosynthetic	NULL
enzymes	NULL
(	NULL
ie	NULL
,	NULL
porphobilinogen	NULL
deaminase	NULL
)	NULL
,	NULL
``	NULL
**	NULL
``	NULL
erythroid-specific	NULL
histone	NULL
protein	NULL
H5	NULL
,	NULL
*	NULL
``	NULL
the	NULL
globins	NULL
,	NULL
``	NULL
``	NULL
the	NULL
erythropoietin	NULL
receptor	NULL
,	NULL
``	NULL
and	NULL
the	NULL
locus	NULL
control	NULL
regions	NULL
of	NULL
the	NULL
a-	NULL
and	NULL
bin	NULL
clusters	NULL
.	NULL

``	NULL
*	NULL
``	NULL
``	NULL
°	NULL
GATA-I	NULL
is	NULL
a	NULL
50-Kd	NULL
DNA	NULL
binding	NULL
protein	NULL
that	NULL
contains	NULL
two	NULL
nearly	NULL
identical	NULL
zinc	NULL
finger	NULL
domains	NULL
.	NULL
``	NULL

The	NULL
structure	NULL
of	NULL
this	NULL
protein	NULL
has	NULL
been	NULL
conserved	NULL
throughout	NULL
vertebrate	NULL
development	NULL
.	NULL

*	NULL
>	NULL
``	NULL
``	NULL
``	NULL
``	NULL
Based	NULL
on	NULL
studies	NULL
of	NULL
embryonic	NULL
stem	NULL
cell	NULL
lines	NULL
containing	NULL
a	NULL
disrupted	NULL
GATA-1	NULL
gene	NULL
,	NULL
GATA-1	NULL
is	NULL
absolutely	NULL
required	NULL
for	NULL
normal	NULL
erythroid	NULL
devel-opment	NULL
.	NULL
``	NULL

GATA-1	NULL
is	NULL
a	NULL
member	NULL
of	NULL
a	NULL
family	NULL
of	NULL
GATA-binding	NULL
pro	NULL
Blood	NULL
,	NULL
Vol	NULL
81	NULL
,	NULL
No	NULL
12	NULL
(	NULL
June	NULL
15	NULL
}	NULL
,	NULL
1993	NULL
:	NULL
pp	NULL
3234-3241	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

MRNA	NULL
FOR	NULL
GATA-BINDING	NULL
PROTEINS	NULL
IN	NULL
EOSINPHILS	NULL
teins	NULL
that	NULL
contain	NULL
a	NULL
similar	NULL
DNA-binding	NULL
domain	NULL
.	NULL
``	NULL

GATA-2	NULL
is	NULL
expressed	NULL
in	NULL
mast	NULL
cells	NULL
,	NULL
megakaryocytes	NULL
,	NULL
and	NULL
erythroid	NULL
cells	NULL
,	NULL
as	NULL
well	NULL
as	NULL
a	NULL
variety	NULL
of	NULL
other	NULL
nonhematopoi-etic	NULL
cells	NULL
.	NULL

``	NULL
*	NULL
``	NULL
``	NULL
GATA-3	NULL
is	NULL
expressed	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
mast	NULL
cells	NULL
,	NULL
and	NULL
embryonic	NULL
brain	NULL
.	NULL
``	NULL

''	NULL
Functional	NULL
analysis	NULL
of	NULL
several	NULL
promoters	NULL
of	NULL
nonerythroid	NULL
genes	NULL
has	NULL
shown	NULL
a	NULL
potential	NULL
role	NULL
for	NULL
transcriptional	NULL
regulation	NULL
by	NULL
the	NULL
GATA-binding	NULL
proteins	NULL
.	NULL

The	NULL
T-cell	NULL
receptor	NULL
«	NULL
and	NULL
8	NULL
chain	NULL
enhancers	NULL
each	NULL
contain	NULL
a	NULL
GATA	NULL
site	NULL
that	NULL
regulates	NULL
activity	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

``	NULL
*	NULL
``	NULL
``	NULL
The	NULL
promoters	NULL
of	NULL
the	NULL
megakaryocytic-specific	NULL
genes	NULL
,	NULL
platelet	NULL
factor	NULL
4	NULL
,	NULL
gplb	NULL
,	NULL
and	NULL
gpllb	NULL
,	NULL
contain	NULL
GATA	NULL
sites	NULL
.	NULL
``	NULL

''	NULL
Disruption	NULL
of	NULL
the	NULL
GATA	NULL
site	NULL
in	NULL
the	NULL
gpllb	NULL
promoter	NULL
disrupts	NULL
function	NULL
of	NULL
the	NULL
promoter	NULL
in	NULL
erythroid/megakaryocytic	NULL
cells	NULL
.	NULL
``	NULL

The	NULL
mast-cell	NULL
carboxypeptidase	NULL
A	NULL
promoter	NULL
contains	NULL
a	NULL
GATA	NULL
site	NULL
,	NULL
the	NULL
mutation	NULL
of	NULL
which	NULL
disrupts	NULL
the	NULL
function	NULL
of	NULL
this	NULL
promoter	NULL
in	NULL
mast	NULL
cells	NULL
.	NULL
``	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
GATA-binding	NULL
proteins	NULL
in	NULL
the	NULL
eosinophil	NULL
and	NULL
basophil	NULL
lineages	NULL
.	NULL

Taken	NULL
together	NULL
with	NULL
previous	NULL
results	NULL
,	NULL
``	NULL
``	NULL
this	NULL
study	NULL
provides	NULL
a	NULL
more	NULL
complete	NULL
analysis	NULL
of	NULL
the	NULL
pattern	NULL
of	NULL
expression	NULL
of	NULL
these	NULL
proteins	NULL
in	NULL
all	NULL
of	NULL
the	NULL
peripheral	NULL
blood	NULL
lineages	NULL
.	NULL

Ad-ditionally	NULL
,	NULL
these	NULL
studies	NULL
suggest	NULL
that	NULL
the	NULL
level	NULL
of	NULL
the	NULL
GATA	NULL
proteins	NULL
is	NULL
developmentally	NULL
regulated	NULL
during	NULL
eosinophil	NULL
maturation	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cells	NULL
and	NULL
cell	NULL
lines	NULL
.	NULL

-	NULL
K562	NULL
,	NULL
Jurkat	NULL
,	NULL
and	NULL
HeLa	NULL
cells	NULL
were	NULL
obtained	NULL
from	NULL
the	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
(	NULL
Rockville	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

Eosinophils	NULL
were	NULL
isolated	NULL
and	NULL
enriched	NULL
from	NULL
patients	NULL
with	NULL
the	NULL
hypereosinophilic	NULL
syndrome	NULL
(	NULL
HES	NULL
)	NULL
by	NULL
leukopheresis	NULL
,	NULL
dextran	NULL
sedimentation	NULL
to	NULL
remove	NULL
red	NULL
blood	NULL
cells	NULL
,	NULL
and	NULL
separation	NULL
over	NULL
gradients	NULL
of	NULL
Ficoll-Hypaque	NULL
(	NULL
Pharmacia	NULL
,	NULL
Piscataway	NULL
,	NULL
NJ	NULL
)	NULL
as	NULL
previously	NULL
de-scribed	NULL
.	NULL

*	NULL
``	NULL
``	NULL
Eosinophils	NULL
were	NULL
also	NULL
obtained	NULL
from	NULL
the	NULL
peritoneal	NULL
dialysate	NULL
of	NULL
a	NULL
patient	NULL
with	NULL
eosinophilia	NULL
secondary	NULL
to	NULL
allergic	NULL
hypersensi-tivity	NULL
;	NULL
cell	NULL
preparations	NULL
contained	NULL
80	NULL
%	NULL
eosinophils	NULL
and	NULL
20	NULL
%	NULL
macrophages	NULL
.	NULL

The	NULL
peritoneal	NULL
eosinophils	NULL
were	NULL
of	NULL
the	NULL
hypodense	NULL
activated	NULL
phenotype	NULL
(	NULL
density	NULL
,	NULL
<	NULL
1.077	NULL
g/mL	NULL
)	NULL
and	NULL
were	NULL
not	NULL
purified	NULL
further	NULL
.	NULL

Basophils	NULL
were	NULL
obtained	NULL
from	NULL
the	NULL
peripheral	NULL
blood	NULL
of	NULL
a	NULL
patient	NULL
with	NULL
chronic	NULL
myelogenous	NULL
leukemia	NULL
(	NULL
CML	NULL
)	NULL
in	NULL
blast	NULL
crisis	NULL
with	NULL
associated	NULL
basophilia	NULL
likewise	NULL
by	NULL
separation	NULL
over	NULL
a	NULL
cushion	NULL
of	NULL
Ficoll-Hypaque	NULL
.	NULL
``	NULL

This	NULL
cell	NULL
population	NULL
contained	NULL
43	NULL
%	NULL
mature	NULL
basophils	NULL
without	NULL
any	NULL
eosinophils	NULL
,	NULL
with	NULL
the	NULL
remainder	NULL
of	NULL
the	NULL
cells	NULL
being	NULL
monocytes	NULL
and	NULL
lymphocytes	NULL
.	NULL

Neutrophils	NULL
were	NULL
isolated	NULL
from	NULL
normal	NULL
donor	NULL
peripheral	NULL
blood	NULL
by	NULL
sedimentation	NULL
through	NULL
a	NULL
cushion	NULL
of	NULL
Ficoll-Hypaque	NULL
.	NULL

Neutrophils	NULL
were	NULL
96	NULL
%	NULL
pure	NULL
,	NULL
with	NULL
the	NULL
remainder	NULL
of	NULL
the	NULL
cells	NULL
being	NULL
eosinophils	NULL
.	NULL

The	NULL
HL-60	NULL
(	NULL
3+C-5	NULL
)	NULL
*	NULL
cell	NULL
line	NULL
was	NULL
a	NULL
generous	NULL
gift	NULL
of	NULL
Dr	NULL
David	NULL
Golde	NULL
(	NULL
University	NULL
of	NULL
Pennsylvania	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Oncology	NULL
Division	NULL
,	NULL
Philadelphia	NULL
,	NULL
PA	NULL
)	NULL
and	NULL
the	NULL
HL-60	NULL
(	NULL
C15	NULL
)	NULL
cell	NULL
line	NULL
was	NULL
a	NULL
generous	NULL
gift	NULL
of	NULL
Dr	NULL
Steven	NULL
Fischkoff	NULL
(	NULL
Memorial	NULL
Sloan-Kettering	NULL
Cancer	NULL
Center	NULL
,	NULL
New	NULL
York	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

Cell	NULL
differentiation	NULL
.	NULL

-	NULL
HL-60	NULL
eosinophilic	NULL
sublines	NULL
were	NULL
induced	NULL
with	NULL
either	NULL
butyric	NULL
acid	NULL
(	NULL
0.5	NULL
mmol/L	NULL
)	NULL
(	NULL
Sigma	NULL
,	NULL
St	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
or	NULL
B-cell	NULL
growth	NULL
factor-II	NULL
(	NULL
BCGF-II	NULL
;	NULL
Cellular	NULL
Products	NULL
Inc	NULL
,	NULL
Buffalo	NULL
,	NULL
NY	NULL
)	NULL
10	NULL
%	NULL
(	NULL
vol/vol	NULL
)	NULL
as	NULL
a	NULL
source	NULL
of	NULL
IL-5	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
in	NULL
log	NULL
phase	NULL
,	NULL
washed	NULL
twice	NULL
in	NULL
RPMI-1640	NULL
,	NULL
resuspended	NULL
at	NULL
2	NULL
X	NULL
10°	NULL
cells/	NULL
mL	NULL
,	NULL
and	NULL
cultured	NULL
for	NULL
1	NULL
to	NULL
7	NULL
days	NULL
in	NULL
complete	NULL
medium	NULL
(	NULL
RPMI	NULL
1640	NULL
containing	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
)	NULL
supplemented	NULL
with	NULL
butyrate	NULL
or	NULL
IL-5	NULL
.	NULL

Control	NULL
inductions	NULL
consisted	NULL
of	NULL
medium	NULL
lacking	NULL
IL-5	NULL
or	NULL
,	NULL
for	NULL
butyrate	NULL
induction	NULL
,	NULL
medium	NULL
containing	NULL
0.1	NULL
%	NULL
ethanol	NULL
.	NULL

Similar	NULL
results	NULL
have	NULL
been	NULL
obtained	NULL
using	NULL
recombinant	NULL
murine	NULL
IL-5	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

At	NULL
various	NULL
time	NULL
points	NULL
,	NULL
cells	NULL
were	NULL
counted	NULL
by	NULL
trypan-blue	NULL
3235	NULL
dye	NULL
exclusion	NULL
and	NULL
cytospin	NULL
preparations	NULL
were	NULL
stained	NULL
with	NULL
Wright's-Giemsa	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
.	NULL

-	NULL
Total	NULL
RNA	NULL
was	NULL
prepared	NULL
from	NULL
different	NULL
populations	NULL
of	NULL
cells	NULL
by	NULL
the	NULL
guanidium	NULL
isothiocyanate	NULL
method	NULL
.	NULL
``	NULL

RNA	NULL
(	NULL
10	NULL
to	NULL
20	NULL
ug/lane	NULL
)	NULL
was	NULL
denatured	NULL
in	NULL
formamide/formalde-hyde	NULL
and	NULL
electrophoresed	NULL
in	NULL
1	NULL
%	NULL
agarose/formaldehyde	NULL
gels	NULL
.	NULL

After	NULL
electrophoresis	NULL
,	NULL
RNA	NULL
was	NULL
transferred	NULL
to	NULL
Magnagraph	NULL
(	NULL
Micron	NULL
Separations	NULL
Inc	NULL
,	NULL
MA	NULL
)	NULL
or	NULL
Hybond-N	NULL
(	NULL
Amersham	NULL
,	NULL
Arlington	NULL
Heights	NULL
,	NULL
IL	NULL
)	NULL
nylon	NULL
membranes	NULL
,	NULL
and	NULL
the	NULL
blots	NULL
probed	NULL
with	NULL
radiolabeled	NULL
cDNAs	NULL
encoding	NULL
human	NULL
GATA-L	NULL
,	NULL
``	NULL
GATA-2	NULL
,	NULL
°	NULL
GATA-3	NULL
,	NULL
``	NULL
CLC	NULL
pro-tein	NULL
,	NULL
``	NULL
ECP	NULL
,	NULL
*	NULL
and	NULL
either	NULL
a	NULL
#	NULL
-actin®*	NULL
or	NULL
288	NULL
ribosomal	NULL
RNA	NULL
probe	NULL
``	NULL
or	NULL
an	NULL
oligonucleotide	NULL
specific	NULL
for	NULL
288	NULL
RNA	NULL
to	NULL
confirm	NULL
equivalent	NULL
RNA	NULL
loading	NULL
.	NULL

All	NULL
hybridizations	NULL
were	NULL
performed	NULL
with	NULL
random-primed	NULL
cDNA	NULL
probes	NULL
at	NULL
42°C	NULL
for	NULL
18	NULL
hours	NULL
in	NULL
50	NULL
%	NULL
formamide	NULL
,	NULL
5	NULL
%	NULL
SSC	NULL
,	NULL
2x	NULL
Denhardt	NULL
's	NULL
buffer	NULL
,	NULL
0.1	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
(	NULL
SDS	NULL
)	NULL
,	NULL
and	NULL
blots	NULL
were	NULL
successively	NULL
washed	NULL
to	NULL
0.2	NULL
x	NULL
SSC	NULL
,	NULL
0.1	NULL
%	NULL
SDS	NULL
at	NULL
65°C	NULL
.	NULL

Autoradiography	NULL
was	NULL
performed	NULL
with	NULL
Kodak	NULL
XAR-5	NULL
film	NULL
(	NULL
East-man	NULL
Kodak	NULL
,	NULL
Rochester	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

Detection	NULL
of	NULL
GATA-1	NULL
mRNA	NULL
by	NULL
reverse	NULL
transcription-polymerase	NULL
chain	NULL
reaction	NULL
(	NULL
RT-PCR	NULL
)	NULL
.	NULL

-	NULL
Oligonucleotide	NULL
PCR	NULL
primers	NULL
for	NULL
human	NULL
GATA-L	NULL
and	NULL
human	NULL
glyceraldehyde-3-phosphate	NULL
dehydrogenase	NULL
(	NULL
GAPDH	NULL
)	NULL
®®	NULL
(	NULL
for	NULL
use	NULL
as	NULL
an	NULL
internal	NULL
standard	NULL
)	NULL
were	NULL
synthesized	NULL
on	NULL
an	NULL
ABI	NULL
Model	NULL
391	NULL
DNA	NULL
synthesizer	NULL
(	NULL
Applied	NULL
Biosystems	NULL
,	NULL
Inc	NULL
,	NULL
Foster	NULL
City	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Total	NULL
cellular	NULL
RNA	NULL
(	NULL
1	NULL
Lg	NULL
)	NULL
for	NULL
each	NULL
sample	NULL
was	NULL
reverse-transcribed	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
20	NULL
gL	NULL
in	NULL
buffer	NULL
containing	NULL
50	NULL
mmol/L	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
8.3	NULL
,	NULL
75	NULL
mmol/L	NULL
KCI	NULL
,	NULL
3	NULL
mmol/L	NULL
MgCl	NULL
;	NULL
,	NULL
10	NULL
mmol/L	NULL
dithiothreitol	NULL
,	NULL
a	NULL
10	NULL
mmol/L	NULL
dNTP	NULL
mixture	NULL
,	NULL
100	NULL
pmol	NULL
random	NULL
hexamer	NULL
oligonucleotides	NULL
(	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
,	NULL
and	NULL
7.5	NULL
U	NULL
of	NULL
AMV	NULL
reverse	NULL
transcriptase	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

The	NULL
cDNA	NULL
was	NULL
then	NULL
amplified	NULL
with	NULL
1	NULL
U	NULL
of	NULL
Vent	NULL
DNA	NULL
polymerase	NULL
(	NULL
New	NULL
England	NULL
Biolabs	NULL
,	NULL
Beverly	NULL
,	NULL
MA	NULL
)	NULL
and	NULL
two	NULL
pairs	NULL
of	NULL
oligonucleotide	NULL
primers	NULL
,	NULL
one	NULL
set	NULL
each	NULL
for	NULL
GATA-1	NULL
(	NULL
5-GGAGCCCTCTCAGCTCAGC-3	NULL
;	NULL
-GCCACCAGCTGGTCCTTCAG-3	NULL
)	NULL
and	NULL
GAPDH	NULL
(	NULL
5-CCA-TGGAGAAGGCTGGGG-3	NULL
;	NULL
5-CAAAGTTGTCATGGATG-ACC-3	NULL
'	NULL
)	NULL
.	NULL

After	NULL
25	NULL
cycles	NULL
on	NULL
a	NULL
thermocycler	NULL
(	NULL
Perkin-Elmer	NULL
Cetus	NULL
,	NULL
Norwalk	NULL
,	NULL
CT	NULL
)	NULL
(	NULL
each	NULL
PCR	NULL
cycle	NULL
included	NULL
denaturation	NULL
at	NULL
94°C	NULL
for	NULL
1	NULL
minute	NULL
,	NULL
annealing	NULL
at	NULL
55°C	NULL
for	NULL
2	NULL
minutes	NULL
,	NULL
and	NULL
extension	NULL
at	NULL
72°C	NULL
for	NULL
2	NULL
minutes	NULL
)	NULL
,	NULL
the	NULL
PCR	NULL
products	NULL
were	NULL
analyzed	NULL
by	NULL
separation	NULL
on	NULL
a	NULL
5	NULL
%	NULL
acrylamide	NULL
gel	NULL
and	NULL
transferred	NULL
onto	NULL
nylon	NULL
membranes	NULL
(	NULL
Hybond	NULL
N	NULL
;	NULL
Amersham	NULL
)	NULL
.	NULL

Membranes	NULL
were	NULL
hybridized	NULL
sequentially	NULL
with	NULL
ran-dom-primed	NULL
P-labeled	NULL
cDNA	NULL
probes	NULL
for	NULL
human	NULL
GATA-1	NULL
and	NULL
human	NULL
GAPDH	NULL
at	NULL
65°C	NULL
in	NULL
50	NULL
%	NULL
formamide	NULL
,	NULL
6x	NULL
SSC	NULL
,	NULL
5	NULL
%	NULL
Den-hardt	NULL
's	NULL
,	NULL
0.5	NULL
%	NULL
SDS	NULL
.	NULL

Filters	NULL
were	NULL
washed	NULL
twice	NULL
in	NULL
2	NULL
%	NULL
SSC	NULL
,	NULL
0.2	NULL
%	NULL
SDS	NULL
at	NULL
55°C	NULL
for	NULL
30	NULL
minutes	NULL
and	NULL
0.2	NULL
%	NULL
SSC	NULL
,	NULL
0.2	NULL
%	NULL
SDS	NULL
at	NULL
60°C	NULL
for	NULL
60	NULL
minutes	NULL
and	NULL
exposed	NULL
to	NULL
film	NULL
for	NULL
1	NULL
to	NULL
6	NULL
hours	NULL
using	NULL
a	NULL
single	NULL
intensifying	NULL
screen	NULL
.	NULL

Blots	NULL
were	NULL
scanned	NULL
using	NULL
a	NULL
Hewlett-Packard	NULL
Scanjet	NULL
He	NULL
and	NULL
GATA-1	NULL
to	NULL
GAPDH	NULL
ratios	NULL
quantitated	NULL
using	NULL
Molecular	NULL
Dynamics	NULL
(	NULL
Sunnyvale	NULL
,	NULL
CA	NULL
)	NULL
Imagequant	NULL
software	NULL
.	NULL

RESULTS	NULL
Northern	NULL
blot	NULL
analysis	NULL
showed	NULL
that	NULL
GATA-1	NULL
mRNA	NULL
was	NULL
highly	NULL
expressed	NULL
in	NULL
eosinophils	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
lanes	NULL
1	NULL
through	NULL
3	NULL
)	NULL
,	NULL
whereas	NULL
expression	NULL
was	NULL
weak	NULL
or	NULL
undetectable	NULL
in	NULL
samples	NULL
of	NULL
basophil	NULL
or	NULL
neutrophil	NULL
mRNA	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
.	NULL

Of	NULL
note	NULL
,	NULL
a	NULL
larger	NULL
2.2-kb	NULL
mRNA	NULL
in	NULL
each	NULL
eosinophil	NULL
sample	NULL
also	NULL
hybridized	NULL
with	NULL
the	NULL
GATA-1	NULL
cDNA	NULL
probe	NULL
(	NULL
Fig	NULL
1	NULL
,	NULL
lanes	NULL
1	NULL
through	NULL
3	NULL
)	NULL
.	NULL

This	NULL
RNA	NULL
species	NULL
was	NULL
not	NULL
detected	NULL
in	NULL
HL-60	NULL
eosinophilic	NULL
sublines	NULL
C15	NULL
or	NULL
3+C-5	NULL
,	NULL
nor	NULL
in	NULL
K562	NULL
RNA	NULL
(	NULL
lanes	NULL
6	NULL
through	NULL
9	NULL
and	NULL
12	NULL
)	NULL
.	NULL

Based	NULL
on	NULL
the	NULL
stringent	NULL
hybridization	NULL
conditions	NULL
used	NULL
for	NULL
the	NULL
Northern	NULL
blot	NULL
analysis	NULL
,	NULL
this	NULL
2.2-kb	NULL
mRNA	NULL
is	NULL
less	NULL
likely	NULL
to	NULL
represent	NULL
mRNA	NULL
for	NULL
another	NULL
cross-hybridizing	NULL
GATA-binding	NULL
protein	NULL
in	NULL
eosinophils	NULL
,	NULL
but	NULL
could	NULL
indicate	NULL
potential	NULL
alternative	NULL
splicing	NULL
or	NULL
polyadenyla-	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

3236	NULL
_	NULL
GATA-1	NULL
I	NULL
’	NULL
_	NULL
'	NULL
.	NULL

1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
910	NULL
1112	NULL
Fig	NULL
1	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
for	NULL
human	NULL
GATA-binding	NULL
protein	NULL
mRNA	NULL
expression	NULL
in	NULL
highly	NULL
enriched	NULL
suspensions	NULL
of	NULL
human	NULL
eosinophils	NULL
,	NULL
basophils	NULL
,	NULL
and	NULL
neutrophils	NULL
.	NULL

Total	NULL
cellular	NULL
RNA	NULL
(	NULL
15	NULL
ug	NULL
)	NULL
was	NULL
loaded	NULL
for	NULL
each	NULL
lane	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
hypodense	NULL
eosinophils	NULL
(	NULL
density	NULL
,	NULL
~1.077	NULL
g/ml	NULL
)	NULL
from	NULL
a	NULL
patient	NULL
with	NULL
the	NULL
hypereosinophilic	NULL
syndrome	NULL
(	NULL
68	NULL
%	NULL
eosinophils	NULL
,	NULL
30	NULL
%	NULL
neutrophils	NULL
,	NULL
2	NULL
%	NULL
mononuclear	NULL
cells	NULL
)	NULL
;	NULL
lane	NULL
2	NULL
,	NULL
more	NULL
normal	NULL
density	NULL
(	NULL
>	NULL
1.077	NULL
g/ml	NULL
)	NULL
eosinophils	NULL
from	NULL
the	NULL
same	NULL
patient	NULL
(	NULL
73	NULL
%	NULL
eosinophils	NULL
,	NULL
27	NULL
%	NULL
neutrophils	NULL
)	NULL
;	NULL
lane	NULL
3	NULL
,	NULL
hypodense	NULL
(	NULL
density	NULL
,	NULL
<	NULL
1.077	NULL
g/ml	NULL
)	NULL
eosinophils	NULL
(	NULL
80	NULL
%	NULL
eosinophils	NULL
,	NULL
20	NULL
%	NULL
macro-phages	NULL
)	NULL
from	NULL
peritoneal	NULL
dialysate	NULL
from	NULL
a	NULL
patient	NULL
with	NULL
allergy	NULL
to	NULL
peritoneal	NULL
dialysis	NULL
;	NULL
lane	NULL
4	NULL
,	NULL
basophil-enriched	NULL
mononuclear	NULL
cell	NULL
fraction	NULL
(	NULL
43	NULL
%	NULL
basophils	NULL
and	NULL
no	NULL
eosinophils	NULL
)	NULL
obtained	NULL
by	NULL
Ficoll-Hypaque	NULL
separation	NULL
of	NULL
blood	NULL
from	NULL
a	NULL
patient	NULL
with	NULL
chronic	NULL
myelogenous	NULL
leukemia	NULL
;	NULL
lane	NULL
5	NULL
,	NULL
purified	NULL
neutrophils	NULL
(	NULL
96	NULL
%	NULL
neutrophils	NULL
,	NULL
4	NULL
%	NULL
eosinophils	NULL
)	NULL
;	NULL
lane	NULL
6	NULL
,	NULL
eosinophil-committed	NULL
subline	NULL
of	NULL
HL-60	NULL
(	NULL
clone	NULL
15	NULL
)	NULL
uninduced	NULL
;	NULL
lane	NULL
7	NULL
,	NULL
clone	NULL
15	NULL
induced	NULL
with	NULL
butyric	NULL
acid	NULL
for	NULL
2	NULL
days	NULL
;	NULL
lane	NULL
8	NULL
,	NULL
eosinophil-committed	NULL
subline	NULL
of	NULL
HL-60	NULL
(	NULL
clone	NULL
3	NULL
+	NULL
C-5	NULL
)	NULL
uninduced	NULL
;	NULL
lane	NULL
9	NULL
,	NULL
clone	NULL
3	NULL
+C-5	NULL
induced	NULL
with	NULL
BCGF-Il	NULL
as	NULL
a	NULL
source	NULL
of	NULL
IL-5	NULL
for	NULL
3	NULL
days	NULL
.	NULL

Controls	NULL
include	NULL
total	NULL
cellular	NULL
RNA	NULL
(	NULL
15	NULL
g	NULL
)	NULL
derived	NULL
from	NULL
Jurkat	NULL
(	NULL
lane	NULL
10	NULL
)	NULL
,	NULL
HeLa	NULL
(	NULL
lane	NULL
11	NULL
)	NULL
,	NULL
and	NULL
the	NULL
erythroleukemia	NULL
cell	NULL
line	NULL
K562	NULL
(	NULL
lane	NULL
12	NULL
)	NULL
.	NULL

tion	NULL
of	NULL
GATA-1	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
GATA-1	NULL
,	NULL
GATA-2	NULL
mRNA	NULL
was	NULL
abundantly	NULL
expressed	NULL
in	NULL
eosinophils	NULL
,	NULL
basophils	NULL
,	NULL
and	NULL
neutrophils	NULL
.	NULL

GATA-3	NULL
mRNA	NULL
was	NULL
expressed	NULL
in	NULL
eosinophils	NULL
and	NULL
basophils	NULL
,	NULL
albeit	NULL
at	NULL
a	NULL
lower	NULL
level	NULL
than	NULL
GATA-1	NULL
,	NULL
and	NULL
not	NULL
at	NULL
all	NULL
in	NULL
neutrophils	NULL
.	NULL

The	NULL
eosinophil	NULL
preparations	NULL
(	NULL
Fig	NULL
1	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
were	NULL
approximately	NULL
70	NULL
%	NULL
pure	NULL
,	NULL
with	NULL
the	NULL
remainder	NULL
of	NULL
cells	NULL
being	NULL
neutrophils	NULL
.	NULL

Because	NULL
neutrophils	NULL
express	NULL
little	NULL
or	NULL
no	NULL
GATA-1	NULL
or	NULL
GATA-3	NULL
,	NULL
their	NULL
presence	NULL
as	NULL
a	NULL
contaminant	NULL
is	NULL
inconsequential	NULL
.	NULL

The	NULL
eosinophil	NULL
preparation	NULL
in	NULL
lane	NULL
3	NULL
was	NULL
80	NULL
%	NULL
pure	NULL
,	NULL
with	NULL
the	NULL
remainder	NULL
of	NULL
the	NULL
cells	NULL
being	NULL
macrophages	NULL
.	NULL

Because	NULL
the	NULL
level	NULL
of	NULL
GATA-binding	NULL
proteins	NULL
in	NULL
highly	NULL
purified	NULL
macrophages	NULL
has	NULL
not	NULL
been	NULL
deter-mined	NULL
,	NULL
their	NULL
presence	NULL
in	NULL
this	NULL
cell	NULL
preparation	NULL
may	NULL
or	NULL
may	NULL
not	NULL
contribute	NULL
to	NULL
the	NULL
detected	NULL
levels	NULL
of	NULL
GATA-1	NULL
,	NULL
GATA-2	NULL
,	NULL
or	NULL
GATA-3	NULL
RNA	NULL
.	NULL

GATA-2	NULL
mRNA	NULL
expression	NULL
detected	NULL
in	NULL
these	NULL
eosinophil	NULL
samples	NULL
could	NULL
be	NULL
due	NULL
in	NULL
part	NULL
to	NULL
GATA-2	NULL
mRNA	NULL
expression	NULL
from	NULL
neutrophils	NULL
or	NULL
macrophages	NULL
.	NULL

Different	NULL
preparations	NULL
of	NULL
basophils	NULL
gave	NULL
trace	NULL
expression	NULL
of	NULL
GATA-1	NULL
mRNA	NULL
and	NULL
variable	NULL
expression	NULL
of	NULL
GATA-2	NULL
mRNA	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

GATA-3	NULL
mRNA	NULL
expression	NULL
detected	NULL
in	NULL
the	NULL
basophils	NULL
could	NULL
partially	NULL
be	NULL
due	NULL
to	NULL
low	NULL
numbers	NULL
of	NULL
T	NULL
lymphocytes	NULL
in	NULL
the	NULL
preparations	NULL
.	NULL

Thus	NULL
,	NULL
similar	NULL
to	NULL
other	NULL
hematopoietic	NULL
lineages	NULL
,	NULL
the	NULL
granulocytic	NULL
lineages	NULL
(	NULL
eo-sinophils	NULL
,	NULL
basophils	NULL
,	NULL
and	NULL
neutrophils	NULL
)	NULL
express	NULL
varying	NULL
levels	NULL
of	NULL
mRNA	NULL
for	NULL
the	NULL
GATA-binding	NULL
proteins	NULL
.	NULL

ZON	NULL
ET	NULL
AL	NULL
To	NULL
determine	NULL
whether	NULL
GATA-1	NULL
,	NULL
GATA-2	NULL
,	NULL
or	NULL
GATA-3	NULL
expression	NULL
was	NULL
developmentally	NULL
regulated	NULL
in	NULL
the	NULL
eosinophil	NULL
lineage	NULL
,	NULL
we	NULL
used	NULL
two	NULL
HL-60	NULL
sublines	NULL
that	NULL
can	NULL
be	NULL
induced	NULL
to	NULL
differentiate	NULL
toward	NULL
the	NULL
eosinophil	NULL
lineage	NULL
.	NULL

GATA-1	NULL
was	NULL
not	NULL
detectable	NULL
by	NULL
Northern	NULL
blot	NULL
analysis	NULL
in	NULL
uninduced	NULL
HL-60	NULL
(	NULL
3+C-5	NULL
)	NULL
cells	NULL
(	NULL
Fig	NULL
1	NULL
,	NULL
lane	NULL
8	NULL
)	NULL
.	NULL

However	NULL
,	NULL
after	NULL
3	NULL
days	NULL
of	NULL
induction	NULL
with	NULL
IL-5	NULL
,	NULL
the	NULL
cells	NULL
expressed	NULL
low	NULL
levels	NULL
of	NULL
GATA1	NULL
mRNA	NULL
(	NULL
lane	NULL
9	NULL
)	NULL
.	NULL

GATA-2	NULL
mRNA	NULL
expression	NULL
was	NULL
both	NULL
greater	NULL
and	NULL
relatively	NULL
constant	NULL
in	NULL
this	NULL
cell	NULL
line	NULL
after	NULL
treatment	NULL
with	NULL
IL-5	NULL
(	NULL
Fig	NULL
1	NULL
,	NULL
lanes	NULL
8	NULL
and	NULL
9	NULL
)	NULL
,	NULL
whereas	NULL
GATA-3	NULL
mRNA	NULL
was	NULL
not	NULL
expressed	NULL
(	NULL
Fig	NULL
1	NULL
,	NULL
lanes	NULL
8	NULL
and	NULL
9	NULL
)	NULL
.	NULL

Because	NULL
of	NULL
the	NULL
low	NULL
levels	NULL
of	NULL
GATA-1	NULL
mRNA	NULL
detectable	NULL
by	NULL
Northern	NULL
blot	NULL
analysis	NULL
in	NULL
the	NULL
HL-60	NULL
(	NULL
3+C-5	NULL
)	NULL
cells	NULL
,	NULL
quantitative	NULL
RT-PCR	NULL
amplification	NULL
of	NULL
GATA-1	NULL
RNA	NULL
transcripts	NULL
was	NULL
used	NULL
to	NULL
study	NULL
expression	NULL
in	NULL
this	NULL
cell	NULL
line	NULL
.	NULL

These	NULL
analyses	NULL
showed	NULL
that	NULL
GATA-1	NULL
mRNA	NULL
levels	NULL
were	NULL
undetectable	NULL
in	NULL
uninduced	NULL
HL-60	NULL
(	NULL
3+C-5	NULL
)	NULL
cells	NULL
1	NULL
day	NULL
after	NULL
the	NULL
addition	NULL
of	NULL
fresh	NULL
medium	NULL
,	NULL
then	NULL
increased	NULL
by	NULL
day	NULL
3	NULL
,	NULL
and	NULL
decreased	NULL
by	NULL
day	NULL
5	NULL
(	NULL
Fig	NULL
2	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
a	NULL
more	NULL
pronounced	NULL
increase	NULL
in	NULL
the	NULL
GATA-1	NULL
level	NULL
was	NULL
evident	NULL
after	NULL
IL-5	NULL
induction	NULL
by	NULL
day	NULL
3	NULL
,	NULL
and	NULL
the	NULL
level	NULL
increased	NULL
further	NULL
by	NULL
day	NULL
5	NULL
.	NULL

No	NULL
GATA-1	NULL
was	NULL
detected	NULL
in	NULL
RNA	NULL
from	NULL
HeLa	NULL
cells	NULL
or	NULL
in	NULL
a	NULL
control	NULL
sample	NULL
without	NULL
template	NULL
(	NULL
no	NULL
RNA	NULL
)	NULL
.	NULL

The	NULL
level	NULL
of	NULL
GATA-1	NULL
expressed	NULL
after	NULL
IL-5	NULL
induction	NULL
was	NULL
a	NULL
fraction	NULL
of	NULL
that	NULL
expressed	NULL
in	NULL
K562	NULL
cells	NULL
.	NULL

The	NULL
level	NULL
of	NULL
mRNA	NULL
for	NULL
CLC	NULL
protein	NULL
,	NULL
a	NULL
marker	NULL
of	NULL
eosinophil	NULL
differentiation	NULL
,	NULL
significantly	NULL
increased	NULL
on	NULL
days	NULL
3	NULL
and	NULL
5	NULL
(	NULL
Fig	NULL
3	NULL
)	NULL
.	NULL

Levels	NULL
of	NULL
mRNA	NULL
encoding	NULL
ECP	NULL
and	NULL
1.0	NULL
-	NULL
IL-5	NULL
.o	NULL
H	NULL
+15	NULL
T	NULL
0.8	NULL
CC	NULL
a	NULL
A	NULL
0.61	NULL
<	NULL
(	NULL
0	NULL
)	NULL
o	NULL
0.41	NULL
*	NULL
.	NULL

E	NULL
02	NULL
E	NULL
0	NULL
&	NULL
5	NULL
:	NULL
0.0	NULL
-	NULL
Pa	NULL
Day	NULL
1	NULL
Day	NULL
3	NULL
Day	NULL
5	NULL
§	NULL
«	NULL
©	NULL
o	NULL
wm	NULL
o	NULL
-o	NULL
#	NULL
$	NULL
=o	NULL
#	NULL
-	NULL
4	NULL
%	NULL
IE	NULL
x	NULL
2	NULL
wun	NULL
tao	NULL
tas	NULL
aud	NULL
tad	NULL
tt	NULL
w	NULL
wt	NULL
=	NULL
GAPDH	NULL
Fig	NULL
2	NULL
.	NULL

-	NULL
RT-PCR	NULL
analysis	NULL
of	NULL
GATA-1	NULL
mRNA	NULL
transcripts	NULL
in	NULL
the	NULL
eosinophil-committed	NULL
subline	NULL
of	NULL
HL-60	NULL
(	NULL
3	NULL
+	NULL
C-5	NULL
)	NULL
induced	NULL
with	NULL
BCGF-II	NULL
as	NULL
a	NULL
source	NULL
of	NULL
IL-5	NULL
for	NULL
5	NULL
days	NULL
.	NULL

Controls	NULL
include	NULL
RNA	NULL
from	NULL
HeLa	NULL
and	NULL
K562	NULL
cells	NULL
and	NULL
a	NULL
sample	NULL
without	NULL
RNA	NULL
.	NULL

Southern	NULL
blot	NULL
for	NULL
GATA-1	NULL
and	NULL
GAPDH	NULL
(	NULL
bottom	NULL
)	NULL
and	NULL
GATA-1	NULL
to	NULL
GAPDH	NULL
ratios	NULL
(	NULL
top	NULL
)	NULL
are	NULL
shown	NULL
for	NULL
uninduced	NULL
(	NULL
-	NULL
)	NULL
and	NULL
BCGF-II-induced	NULL
(	NULL
+	NULL
)	NULL
cell	NULL
preparations	NULL
at	NULL
the	NULL
indicated	NULL
times	NULL
.	NULL

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

mRNA	NULL
FOR	NULL
GATA-BINDING	NULL
PROTEINS	NULL
IN	NULL
EOSINPHILS	NULL
I..—	NULL
DAY	NULL
1	NULL
U	NULL
IL-5	NULL
Fig	NULL
3	NULL
.	NULL

-	NULL
Northern	NULL
blot	NULL
analysis	NULL
of	NULL
mRNA	NULL
for	NULL
CLC	NULL
protein	NULL
expressed	NULL
in	NULL
HL-60	NULL
(	NULL
3+C-5	NULL
)	NULL
cells	NULL
induced	NULL
with	NULL
IL-5	NULL
.	NULL

The	NULL
eosinophil-committed	NULL
subline	NULL
of	NULL
HL-60	NULL
(	NULL
clone	NULL
3	NULL
+C-5	NULL
)	NULL
was	NULL
grown	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
lanes	NULL
1	NULL
,	NULL
3	NULL
,	NULL
and	NULL
5	NULL
)	NULL
or	NULL
presence	NULL
(	NULL
lanes	NULL
2	NULL
,	NULL
4	NULL
,	NULL
and	NULL
6	NULL
)	NULL
of	NULL
10	NULL
%	NULL
BCGF-II	NULL
as	NULL
a	NULL
source	NULL
of	NULL
IL-5	NULL
for	NULL
up	NULL
to	NULL
72	NULL
hours	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
obtained	NULL
at	NULL
day	NULL
1	NULL
,	NULL
3	NULL
,	NULL
and	NULL
5	NULL
of	NULL
culture	NULL
.	NULL

The	NULL
Northern	NULL
blot	NULL
containing	NULL
10	NULL
ug	NULL
of	NULL
total	NULL
RNA	NULL
from	NULL
cells	NULL
at	NULL
each	NULL
time	NULL
point	NULL
was	NULL
simultaneously	NULL
hybridized	NULL
with	NULL
a	NULL
*°P-labeled	NULL
529-bp	NULL
cDNA	NULL
fragment	NULL
encompassing	NULL
the	NULL
entire	NULL
coding	NULL
plus	NULL
5	NULL
'	NULL
untranslated	NULL
region	NULL
of	NULL
the	NULL
CLC	NULL
cDNA	NULL
and	NULL
a	NULL
2-kb	NULL
fragment	NULL
of	NULL
chicken	NULL
#	NULL
-actin	NULL
cDNA	NULL
as	NULL
a	NULL
control	NULL
for	NULL
RNA	NULL
loading	NULL
.	NULL

EDN	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
increase	NULL
in	NULL
the	NULL
HL-60	NULL
3+C-5	NULL
line	NULL
induced	NULL
with	NULL
BCGF-II	NULL
as	NULL
a	NULL
source	NULL
of	NULL
IL-5.°38	NULL
As	NULL
shown	NULL
in	NULL
Fig	NULL
4	NULL
,	NULL
butyrate	NULL
induction	NULL
of	NULL
the	NULL
HL-60	NULL
(	NULL
C15	NULL
)	NULL
subline	NULL
resulted	NULL
in	NULL
the	NULL
formation	NULL
of	NULL
granules	NULL
by	NULL
day	NULL
3	NULL
,	NULL
consistent	NULL
with	NULL
differentiation	NULL
towards	NULL
the	NULL
eosinophil	NULL
lineage	NULL
.	NULL

Compared	NULL
with	NULL
the	NULL
IL-5	NULL
induction	NULL
of	NULL
HL-60	NULL
(	NULL
3+C-5	NULL
)	NULL
,	NULL
which	NULL
does	NULL
not	NULL
induce	NULL
any	NULL
significant	NULL
morphologic	NULL
differentiation	NULL
,	NULL
a	NULL
more	NULL
pronounced	NULL
induction	NULL
of	NULL
GATA-1	NULL
(	NULL
Fig	NULL
1	NULL
,	NULL
lanes	NULL
6	NULL
and	NULL
7	NULL
,	NULL
and	NULL
Fig	NULL
5B	NULL
)	NULL
and	NULL
GATA-3	NULL
(	NULL
Fig	NULL
1	NULL
,	NULL
lanes	NULL
6	NULL
and	NULL
7	NULL
)	NULL
mRNA	NULL
expression	NULL
was	NULL
seen	NULL
in	NULL
the	NULL
HL-60	NULL
(	NULL
C15	NULL
)	NULL
subline	NULL
after	NULL
butyrate	NULL
treatment	NULL
.	NULL

The	NULL
upper	NULL
band	NULL
in	NULL
the	NULL
GATA-3	NULL
hybridization	NULL
seen	NULL
in	NULL
lanes	NULL
6	NULL
and	NULL
7	NULL
,	NULL
which	NULL
was	NULL
not	NULL
evident	NULL
in	NULL
Jurkat	NULL
cells	NULL
(	NULL
lane	NULL
10	NULL
)	NULL
,	NULL
likely	NULL
represents	NULL
potential	NULL
alternative	NULL
processing	NULL
or	NULL
polyadenylation	NULL
of	NULL
GATA-3	NULL
,	NULL
rather	NULL
than	NULL
mRNA	NULL
for	NULL
another	NULL
cross-hybridizing	NULL
GATA-binding	NULL
protein	NULL
.	NULL

The	NULL
size	NULL
of	NULL
this	NULL
transcript	NULL
is	NULL
identical	NULL
to	NULL
GATA-2	NULL
,	NULL
but	NULL
is	NULL
unlikely	NULL
to	NULL
represent	NULL
GATA-2	NULL
expression	NULL
because	NULL
other	NULL
m	NULL
A	NULL
|	NULL
B	NULL
3237	NULL
HL-60	NULL
(	NULL
3+C5	NULL
)	NULL
--	NULL
DAY	NULL
3	NULL
DAY	NULL
5	NULL
U	NULL
IL-5	NULL
-	NULL
U	NULL
L-S5	NULL
RNA	NULL
samples	NULL
that	NULL
expressed	NULL
GATA-2	NULL
did	NULL
not	NULL
hybridize	NULL
to	NULL
the	NULL
GATA-3	NULL
probe	NULL
(	NULL
lanes	NULL
5	NULL
,	NULL
8	NULL
,	NULL
and	NULL
9	NULL
)	NULL
.	NULL

GATA-2	NULL
mRNA	NULL
was	NULL
constitutively	NULL
expressed	NULL
in	NULL
both	NULL
eosinophilic	NULL
sublines	NULL
of	NULL
HL-60	NULL
(	NULL
Fig	NULL
1	NULL
,	NULL
lanes	NULL
6	NULL
through	NULL
9	NULL
)	NULL
.	NULL

It	NULL
is	NULL
noteworthy	NULL
that	NULL
the	NULL
level	NULL
of	NULL
GATA-2	NULL
mRNA	NULL
is	NULL
substantially	NULL
higher	NULL
than	NULL
that	NULL
expressed	NULL
in	NULL
the	NULL
uninduced	NULL
parental	NULL
HL-60	NULL
cell	NULL
line	NULL
(	NULL
ATCC	NULL
CCL-240	NULL
)	NULL
.	NULL

``	NULL
>	NULL
``	NULL
As	NULL
a	NULL
marker	NULL
of	NULL
the	NULL
eosinophilic	NULL
differentiation	NULL
of	NULL
this	NULL
HL-60	NULL
subline	NULL
,	NULL
ECP	NULL
RNA	NULL
transcripts	NULL
,	NULL
which	NULL
were	NULL
evident	NULL
in	NULL
the	NULL
uninduced	NULL
cells	NULL
(	NULL
day	NULL
0	NULL
)	NULL
,	NULL
were	NULL
significantly	NULL
increased	NULL
by	NULL
days	NULL
1	NULL
to	NULL
3	NULL
(	NULL
Fig	NULL
5A	NULL
)	NULL
.	NULL

The	NULL
levels	NULL
of	NULL
mRNA	NULL
for	NULL
CLC	NULL
protein	NULL
were	NULL
similarly	NULL
induced	NULL
in	NULL
the	NULL
HL-60	NULL
C15	NULL
subline	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

DISCUSSION	NULL
The	NULL
GATA-binding	NULL
proteins	NULL
are	NULL
expressed	NULL
at	NULL
different	NULL
levels	NULL
in	NULL
the	NULL
eosinophil	NULL
and	NULL
basophil	NULL
lineages	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
level	NULL
of	NULL
these	NULL
transcription	NULL
factors	NULL
varies	NULL
substantially	NULL
in	NULL
Fig	NULL
4	NULL
.	NULL

Induction	NULL
of	NULL
eosinophilic	NULL
differentiation	NULL
of	NULL
HL-60	NULL
(	NULL
C15	NULL
)	NULL
cells	NULL
by	NULL
butyric	NULL
acid	NULL
.	NULL

HL-60	NULL
#	NULL
(	NULL
clone	NULL
15	NULL
)	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
A	NULL
)	NULL
‘	NULL
or	NULL
presence	NULL
(	NULL
B	NULL
)	NULL
of	NULL
0.5	NULL
mmol/L	NULL
butyric	NULL
acid	NULL
for	NULL
5	NULL
days	NULL
.	NULL

The	NULL
photomicrographs	NULL
of	NULL
Wright's-Giemsa	NULL
stained	NULL
cytocentrifuge	NULL
slides	NULL
clearly	NULL
show	NULL
the	NULL
development	NULL
of	NULL
marked	NULL
granulation	NULL
in	NULL
the	NULL
induced	NULL
cells	NULL
as	NULL
compared	NULL
with	NULL
that	NULL
in	NULL
the	NULL
uninduced	NULL
line	NULL
;	NULL
large	NULL
numbers	NULL
of	NULL
metachromati-cally	NULL
stained	NULL
granules	NULL
consistent	NULL
with	NULL
the	NULL
development	NULL
of	NULL
immature	NULL
eosinophil	NULL
granules	NULL
can	NULL
be	NULL
®	NULL
clearly	NULL
seen	NULL
(	NULL
original	NULL
magnification	NULL
X	NULL
1,000	NULL
)	NULL
.	NULL

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

3238	NULL
HL-60	NULL
(	NULL
C15	NULL
)	NULL
-	NULL
U	NULL
0	NULL
1	NULL
3	NULL
§	NULL
7	NULL
4-28	NULL
S	NULL
#	NULL
f	NULL
a	NULL
HL-60	NULL
(	NULL
C15	NULL
)	NULL
U	NULL
Butyrate	NULL
TA	NULL
-~1	NULL
Day	NULL
0	NULL
1	NULL
3	NULL
5	NULL
7	NULL
_	NULL
]	NULL
x562	NULL
(	NULL
pos	NULL
.	NULL

at	NULL
!	NULL
)	NULL

JHeLa	NULL
(	NULL
neg	NULL
.	NULL

ctl	NULL
.	NULL
)	NULL

*s	NULL
a	NULL
GATA1	NULL
Actin	NULL
Fig	NULL
5	NULL
.	NULL

Induced	NULL
expression	NULL
of	NULL
GATA-1	NULL
and	NULL
ECP	NULL
mRNA	NULL
in	NULL
HL-60-C15	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Northern	NULL
blot	NULL
analysis	NULL
for	NULL
ECP	NULL
mRNA	NULL
in	NULL
HL-60-C15	NULL
cells	NULL
induced	NULL
with	NULL
0.5	NULL
mmol/L	NULL
butyric	NULL
acid	NULL
for	NULL
7	NULL
days	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
obtained	NULL
from	NULL
the	NULL
cells	NULL
at	NULL
the	NULL
indicated	NULL
time	NULL
points	NULL
.	NULL

The	NULL
blot	NULL
containing	NULL
total	NULL
RNA	NULL
(	NULL
20	NULL
ug/lane	NULL
)	NULL
from	NULL
cells	NULL
at	NULL
each	NULL
time	NULL
point	NULL
was	NULL
probed	NULL
sequentially	NULL
with	NULL
cDNA	NULL
probes	NULL
for	NULL
ECP	NULL
and	NULL
a	NULL
28S	NULL
ribosomal	NULL
RNA	NULL
probe	NULL
used	NULL
to	NULL
ensure	NULL
equivalent	NULL
loading	NULL
in	NULL
all	NULL
lanes	NULL
.	NULL

The	NULL
decrease	NULL
in	NULL
ECP	NULL
mRNA	NULL
at	NULL
7	NULL
days	NULL
likely	NULL
reflects	NULL
decreased	NULL
cell	NULL
viability	NULL
in	NULL
the	NULL
cultures	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Northern	NULL
blot	NULL
analysis	NULL
for	NULL
GATA-1	NULL
mRNA	NULL
expression	NULL
in	NULL
the	NULL
eosinophilic	NULL
HL-60-C15	NULL
induced	NULL
with	NULL
butyric	NULL
acid	NULL
.	NULL

Controls	NULL
included	NULL
RNA	NULL
from	NULL
the	NULL
erythroleukemia	NULL
cell	NULL
line	NULL
K562	NULL
and	NULL
from	NULL
HeLa	NULL
cells	NULL
.	NULL

two	NULL
cell	NULL
lines	NULL
that	NULL
can	NULL
be	NULL
induced	NULL
to	NULL
express	NULL
eosinophil-specific	NULL
genes	NULL
.	NULL

The	NULL
relative	NULL
expression	NULL
level	NULL
of	NULL
GATA-1	NULL
and	NULL
GATA-3	NULL
in	NULL
the	NULL
HL-60	NULL
C15	NULL
cell	NULL
line	NULL
was	NULL
substantially	NULL
higher	NULL
than	NULL
in	NULL
the	NULL
3+C-5	NULL
cell	NULL
line	NULL
.	NULL

These	NULL
cell	NULL
lines	NULL
likely	NULL
represent	NULL
two	NULL
stages	NULL
of	NULL
differentiation	NULL
of	NULL
the	NULL
eosinophil	NULL
lineage	NULL
.	NULL

The	NULL
induction	NULL
conditions	NULL
for	NULL
the	NULL
two	NULL
cell	NULL
lines	NULL
differs	NULL
;	NULL
C15	NULL
is	NULL
inducible	NULL
with	NULL
butyrate	NULL
,	NULL
but	NULL
not	NULL
inducible	NULL
with	NULL
IL-5	NULL
.	NULL

The	NULL
3+C-5	NULL
line	NULL
is	NULL
inducible	NULL
with	NULL
IL-5	NULL
,	NULL
but	NULL
not	NULL
butyrate	NULL
(	NULL
Yama-guchi	NULL
and	NULL
Ackerman	NULL
,	NULL
unpublished	NULL
observations	NULL
)	NULL
.	NULL

Likewise	NULL
,	NULL
the	NULL
formation	NULL
of	NULL
granules	NULL
is	NULL
more	NULL
prominent	NULL
in	NULL
the	NULL
C15	NULL
cell	NULL
ZON	NULL
ET	NULL
AL	NULL
inductions	NULL
,	NULL
whereas	NULL
no	NULL
morphologic	NULL
changes	NULL
occur	NULL
with	NULL
IL-5	NULL
induction	NULL
of	NULL
3+C-5	NULL
cells	NULL
.	NULL

The	NULL
different	NULL
induction	NULL
conditions	NULL
could	NULL
account	NULL
for	NULL
the	NULL
differences	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
GATA-binding	NULL
proteins	NULL
.	NULL

These	NULL
studies	NULL
have	NULL
examined	NULL
the	NULL
level	NULL
of	NULL
RNA	NULL
expression	NULL
for	NULL
the	NULL
GATA-binding	NULL
pro-teins	NULL
;	NULL
studies	NULL
of	NULL
these	NULL
transcription	NULL
factors	NULL
at	NULL
the	NULL
protein	NULL
level	NULL
await	NULL
the	NULL
availability	NULL
of	NULL
specific	NULL
antisera	NULL
.	NULL

Preliminary	NULL
results	NULL
based	NULL
on	NULL
Western	NULL
blot	NULL
analysis	NULL
with	NULL
antisera	NULL
directed	NULL
to	NULL
GATA-1	NULL
suggest	NULL
that	NULL
GATA-1	NULL
RNA	NULL
levels	NULL
correlate	NULL
with	NULL
protein	NULL
level	NULL
during	NULL
erythroid	NULL
development	NULL
(	NULL
Zon	NULL
,	NULL
unpublished	NULL
results	NULL
)	NULL
.	NULL

Because	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
level	NULL
of	NULL
GATA-1	NULL
and	NULL
GATA-3	NULL
mRNA	NULL
is	NULL
upregulated	NULL
during	NULL
the	NULL
induction	NULL
of	NULL
one	NULL
or	NULL
both	NULL
of	NULL
the	NULL
HL-60	NULL
eosinophilic	NULL
cell	NULL
lines	NULL
(	NULL
Figs	NULL
1	NULL
,	NULL
2	NULL
,	NULL
and	NULL
5B	NULL
)	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
these	NULL
proteins	NULL
may	NULL
be	NULL
developmentally	NULL
regulated	NULL
during	NULL
normal	NULL
eosinophil	NULL
differentiation	NULL
and	NULL
have	NULL
functional	NULL
relevance	NULL
to	NULL
gene	NULL
expression	NULL
by	NULL
the	NULL
eosinophil	NULL
lineage	NULL
.	NULL

This	NULL
study	NULL
of	NULL
the	NULL
granulocytic	NULL
lineages	NULL
,	NULL
taken	NULL
together	NULL
with	NULL
previous	NULL
findings	NULL
,	NULL
``	NULL
``	NULL
*	NULL
'	NULL
provides	NULL
a	NULL
more	NULL
complete	NULL
analysis	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
known	NULL
GATA-binding	NULL
proteins	NULL
in	NULL
the	NULL
committed	NULL
peripheral	NULL
blood	NULL
cell	NULL
lineages	NULL
.	NULL

The	NULL
hematopoietic	NULL
lineages	NULL
express	NULL
GATA-binding	NULL
proteins	NULL
as	NULL
fol-lows	NULL
:	NULL
GATA-1	NULL
in	NULL
erythroid	NULL
,	NULL
megakaryocyte	NULL
,	NULL
mast	NULL
cell	NULL
,	NULL
and	NULL
eosinophil	NULL
lineages	NULL
;	NULL
GATA-2	NULL
in	NULL
mast	NULL
cell	NULL
,	NULL
basophil	NULL
,	NULL
eosinophil	NULL
,	NULL
neutrophil	NULL
,	NULL
megakaryocyte	NULL
,	NULL
and	NULL
erythroid	NULL
lineages	NULL
;	NULL
and	NULL
GATA-3	NULL
in	NULL
T-cell	NULL
,	NULL
mast-cell	NULL
,	NULL
eosinophil	NULL
,	NULL
and	NULL
,	NULL
possibly	NULL
,	NULL
basophil	NULL
lineages	NULL
.	NULL

Preliminary	NULL
studies	NULL
of	NULL
enriched	NULL
monocytes	NULL
indicate	NULL
that	NULL
GATA-2	NULL
is	NULL
expressed	NULL
in	NULL
this	NULL
lineage	NULL
,	NULL
although	NULL
conclusive	NULL
evidence	NULL
awaits	NULL
analyses	NULL
of	NULL
more	NULL
highly	NULL
purified	NULL
preparations	NULL
.	NULL

Of	NULL
note	NULL
,	NULL
there	NULL
is	NULL
overlap	NULL
of	NULL
lineage	NULL
expression	NULL
,	NULL
and	NULL
particular	NULL
lineages	NULL
favor	NULL
high	NULL
level	NULL
expression	NULL
of	NULL
one	NULL
of	NULL
the	NULL
factors	NULL
,	NULL
ie	NULL
,	NULL
GATA-1	NULL
in	NULL
erythroid	NULL
cells	NULL
,	NULL
GATA-2	NULL
in	NULL
mast	NULL
cells	NULL
,	NULL
and	NULL
GATA-3	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

In	NULL
the	NULL
eosinophil	NULL
,	NULL
it	NULL
appears	NULL
that	NULL
GATA-1	NULL
and	NULL
GATA-2	NULL
expression	NULL
predominates	NULL
over	NULL
GATA-3	NULL
.	NULL

Because	NULL
each	NULL
of	NULL
these	NULL
factors	NULL
binds	NULL
to	NULL
a	NULL
core	NULL
GATA	NULL
sequence	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
during	NULL
the	NULL
development	NULL
of	NULL
each	NULL
hematopoietic	NULL
lineage	NULL
,	NULL
a	NULL
GATA	NULL
site	NULL
in	NULL
the	NULL
promoter	NULL
or	NULL
enhancer	NULL
of	NULL
a	NULL
particular	NULL
gene	NULL
may	NULL
be	NULL
contacted	NULL
and	NULL
activated	NULL
by	NULL
distinct	NULL
GATA-binding	NULL
proteins	NULL
.	NULL

Preferential	NULL
binding	NULL
to	NULL
particular	NULL
GATA	NULL
sites	NULL
based	NULL
on	NULL
different	NULL
affinities	NULL
to	NULL
flanking	NULL
sequences	NULL
could	NULL
specify	NULL
which	NULL
GATA-binding	NULL
protein	NULL
activates	NULL
an	NULL
individual	NULL
promoter	NULL
in	NULL
vivo	NULL
.	NULL

GATA-1	NULL
,	NULL
GATA-2	NULL
,	NULL
and	NULL
GATA-3	NULL
are	NULL
likely	NULL
to	NULL
function	NULL
as	NULL
transcriptional	NULL
activators	NULL
in	NULL
granulocytic	NULL
cells	NULL
,	NULL
similar	NULL
to	NULL
their	NULL
role	NULL
in	NULL
erythroid	NULL
cells	NULL
.	NULL

Two	NULL
mechanisms	NULL
in	NULL
erythroid	NULL
cells	NULL
function	NULL
to	NULL
maintain	NULL
lineage	NULL
survival	NULL
.	NULL

First	NULL
,	NULL
GATA-1	NULL
is	NULL
capable	NULL
of	NULL
positive	NULL
autoregulation	NULL
through	NULL
a	NULL
tandem	NULL
GATA	NULL
site	NULL
in	NULL
its	NULL
own	NULL
promoter	NULL
.	NULL
``	NULL

Second	NULL
,	NULL
GATA-1	NULL
regulates	NULL
the	NULL
erythropoietin	NULL
receptor	NULL
promoter	NULL
,	NULL
``	NULL
allowing	NULL
a	NULL
proliferative	NULL
signal	NULL
to	NULL
occur	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
erythropoietin	NULL
,	NULL
which	NULL
prevents	NULL
programmed	NULL
cell	NULL
death	NULL
.	NULL

Because	NULL
IL-5	NULL
is	NULL
capable	NULL
of	NULL
inducing	NULL
the	NULL
expression	NULL
of	NULL
GATA-1	NULL
and	NULL
GATA-2	NULL
,	NULL
the	NULL
genes	NULL
for	NULL
these	NULL
transcription	NULL
factors	NULL
may	NULL
be	NULL
directly	NULL
responsive	NULL
to	NULL
the	NULL
action	NULL
of	NULL
IL-5	NULL
.	NULL

IL-5	NULL
,	NULL
which	NULL
prevents	NULL
apoptosis	NULL
in	NULL
mature	NULL
eosinophils	NULL
,	NULL
``	NULL
may	NULL
additionally	NULL
function	NULL
to	NULL
maintain	NULL
the	NULL
GATA-1	NULL
autoregulatory	NULL
loop	NULL
in	NULL
eosinophils	NULL
,	NULL
similar	NULL
to	NULL
the	NULL
function	NULL
of	NULL
erythropoietin	NULL
in	NULL
erythroid	NULL
cells	NULL
.	NULL

The	NULL
IL-5	NULL
receptor	NULL
may	NULL
be	NULL
similarly	NULL
regulated	NULL
by	NULL
the	NULL
GATA-binding	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

mRNA	NULL
FOR	NULL
GATA-BINDING	NULL
PROTEINS	NULL
IN	NULL
EOSINPHILS	NULL
proteins	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
butyrate	NULL
induction	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
induce	NULL
the	NULL
expression	NULL
of	NULL
high-affinity	NULL
receptors	NULL
for	NULL
IL-5	NULL
in	NULL
the	NULL
C15	NULL
eosinophilic	NULL
subline	NULL
of	NULL
HL-60	NULL
.	NULL
``	NULL

''	NULL
GATA-1	NULL
expression	NULL
is	NULL
activated	NULL
in	NULL
the	NULL
HL-60	NULL
subline	NULL
,	NULL
3+C-5	NULL
,	NULL
with	NULL
the	NULL
addition	NULL
of	NULL
fresh	NULL
medium	NULL
after	NULL
log	NULL
phase	NULL
growth	NULL
;	NULL
induction	NULL
with	NULL
IL-5	NULL
in	NULL
this	NULL
cell	NULL
line	NULL
appears	NULL
to	NULL
increase	NULL
and	NULL
prolong	NULL
the	NULL
expression	NULL
of	NULL
GATA-1	NULL
mRNA	NULL
.	NULL

This	NULL
may	NULL
represent	NULL
effects	NULL
of	NULL
cell-cycle-dependent	NULL
initiation	NULL
of	NULL
GATA-1	NULL
expression	NULL
,	NULL
a	NULL
process	NULL
that	NULL
has	NULL
recently	NULL
been	NULL
described	NULL
in	NULL
synchronized	NULL
differentiation	NULL
of	NULL
purified	NULL
hematopoietic	NULL
progenitors	NULL
to	NULL
either	NULL
the	NULL
erythroid	NULL
or	NULL
granulocytic	NULL
lineages	NULL
.	NULL
``	NULL

Studies	NULL
of	NULL
eosinophil	NULL
gene	NULL
transcription	NULL
have	NULL
not	NULL
yet	NULL
defined	NULL
functional	NULL
cell-specific	NULL
regulatory	NULL
elements	NULL
.	NULL

However	NULL
,	NULL
based	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
GATA-binding	NULL
proteins	NULL
in	NULL
the	NULL
lineage	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
some	NULL
eosinophil-specific	NULL
genes	NULL
will	NULL
be	NULL
regulated	NULL
by	NULL
these	NULL
factors	NULL
,	NULL
similar	NULL
to	NULL
the	NULL
a	NULL
and	NULL
8	NULL
receptor	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
mast	NULL
cell-carboxypeptidase	NULL
A	NULL
(	NULL
MC-CPA	NULL
)	NULL
in	NULL
mast	NULL
cells	NULL
,	NULL
gpllb	NULL
in	NULL
megakaryocytes	NULL
,	NULL
or	NULL
the	NULL
globins	NULL
in	NULL
erythroid	NULL
cells	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
the	NULL
5	NULL
putative	NULL
promoter	NULL
regions	NULL
of	NULL
four	NULL
of	NULL
the	NULL
five	NULL
eosinophil	NULL
granule	NULL
protein	NULL
genes	NULL
that	NULL
have	NULL
been	NULL
cloned	NULL
(	NULL
MBP	NULL
,	NULL
``	NULL
``	NULL
ECP	NULL
``	NULL
[	NULL
Ackerman	NULL
,	NULL
Dvorak	NULL
,	NULL
Tenen	NULL
,	NULL
unpublished	NULL
data	NULL
)	NULL
,	NULL
EDN	NULL
,	NULL
``	NULL
*	NULL
and	NULL
CLC	NULL
protein	NULL
[	NULL
Go-molin	NULL
,	NULL
Yamaguchi	NULL
,	NULL
Paulpillai	NULL
,	NULL
Dvorak	NULL
,	NULL
Ackerman	NULL
,	NULL
and	NULL
Tenen	NULL
,	NULL
submitted	NULL
]	NULL
)	NULL
each	NULL
contain	NULL
potential	NULL
target	NULL
GATA-binding	NULL
sites	NULL
.	NULL

Further	NULL
functional	NULL
analyses	NULL
will	NULL
be	NULL
required	NULL
to	NULL
determine	NULL
whether	NULL
these	NULL
sites	NULL
are	NULL
required	NULL
for	NULL
the	NULL
eosinophil-specific	NULL
gene	NULL
regulation	NULL
of	NULL
these	NULL
promoters	NULL
.	NULL

ACKNOWLEDGMENT	NULL
The	NULL
authors	NULL
thank	NULL
Dr	NULL
Daniel	NULL
Tenen	NULL
for	NULL
scientific	NULL
input	NULL
and	NULL
critical	NULL
review	NULL
of	NULL
the	NULL
manuscript	NULL
,	NULL
Dr	NULL
Peter	NULL
Weller	NULL
for	NULL
access	NULL
to	NULL
cells	NULL
from	NULL
a	NULL
patient	NULL
with	NULL
the	NULL
hypereosinophilic	NULL
syndrome	NULL
,	NULL
Dr	NULL
Josef	NULL
Mich	NULL
]	NULL
and	NULL
Juana	NULL
Gonzalez	NULL
for	NULL
eosinophils	NULL
from	NULL
the	NULL
peritoneal	NULL
dialysis	NULL
fluid	NULL
,	NULL
and	NULL
Dr	NULL
Larry	NULL
Shulman	NULL
for	NULL
making	NULL
cells	NULL
available	NULL
from	NULL
patients	NULL
with	NULL
CML	NULL
and	NULL
basophilia	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Gleich	NULL
GJ	NULL
,	NULL
Adolphson	NULL
CR	NULL
:	NULL
The	NULL
eosinophilic	NULL
leukocyte	NULL
:	NULL
Structure	NULL
and	NULL
function	NULL
.	NULL

Adv	NULL
Immunol	NULL
39:177	NULL
,	NULL
1986	NULL
2	NULL
.	NULL

Marone	NULL
G	NULL
,	NULL
Casolaro	NULL
V	NULL
,	NULL
Cirillo	NULL
R	NULL
,	NULL
Stellato	NULL
C	NULL
,	NULL
Genovese	NULL
A	NULL
:	NULL
Pathophysiology	NULL
of	NULL
human	NULL
basophils	NULL
and	NULL
mast	NULL
cells	NULL
in	NULL
allergic	NULL
dis-orders	NULL
.	NULL

Clin	NULL
Immunol	NULL
Immunopathol	NULL
50:524	NULL
,	NULL
1989	NULL
3	NULL
.	NULL

Butterworth	NULL
AE	NULL
:	NULL
Cell-mediated	NULL
damage	NULL
to	NULL
helminths	NULL
.	NULL

Adv	NULL
Parasitol	NULL
23:143	NULL
,	NULL
1984	NULL
4	NULL
.	NULL

Denburg	NULL
JA	NULL
,	NULL
Telizyn	NULL
S	NULL
,	NULL
Messner	NULL
H	NULL
,	NULL
Lim	NULL
B	NULL
,	NULL
Jamal	NULL
N	NULL
,	NULL
Ackerman	NULL
SJ	NULL
,	NULL
Gleich	NULL
GJ	NULL
,	NULL
Bienenstock	NULL
J	NULL
:	NULL
Heterogeneity	NULL
of	NULL
human	NULL
peripheral	NULL
blood	NULL
eosinophil-type	NULL
colonies	NULL
:	NULL
Evidence	NULL
for	NULL
a	NULL
common	NULL
baso-phil-eosinophil	NULL
progenitor	NULL
.	NULL

Blood	NULL
66:312	NULL
,	NULL
1985	NULL
5	NULL
.	NULL

O'Donnell	NULL
MC	NULL
,	NULL
Ackerman	NULL
SJ	NULL
,	NULL
Gleich	NULL
GJ	NULL
,	NULL
Thomas	NULL
LL	NULL
:	NULL
Activation	NULL
of	NULL
basophil	NULL
and	NULL
mast	NULL
cell	NULL
histamine	NULL
release	NULL
by	NULL
eosinophil	NULL
granule	NULL
major	NULL
basic	NULL
protein	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
157:1981	NULL
,	NULL
1983	NULL
6	NULL
.	NULL

Zheutlin	NULL
LM	NULL
,	NULL
Ackerman	NULL
SJ	NULL
,	NULL
Gleich	NULL
GJ	NULL
,	NULL
Thomas	NULL
LL	NULL
:	NULL
Stimulation	NULL
of	NULL
basophil	NULL
and	NULL
rat	NULL
mast	NULL
cell	NULL
histamine	NULL
release	NULL
by	NULL
eosinophil	NULL
granule-derived	NULL
cationic	NULL
proteins	NULL
.	NULL

J	NULL
Immunol	NULL
133:2180	NULL
,	NULL
1984	NULL
7	NULL
.	NULL

Ackerman	NULL
SJ	NULL
,	NULL
Loegering	NULL
DA	NULL
,	NULL
Venge	NULL
P	NULL
,	NULL
Olsson	NULL
I	NULL
,	NULL
Harley	NULL
JB	NULL
,	NULL
Fauci	NULL
AS	NULL
,	NULL
Gleich	NULL
GJ	NULL
:	NULL
Distinctive	NULL
cationic	NULL
proteins	NULL
of	NULL
the	NULL
human	NULL
eosinophil	NULL
granule	NULL
:	NULL
Major	NULL
basic	NULL
protein	NULL
,	NULL
eosinophilic	NULL
cationic	NULL
protein	NULL
,	NULL
and	NULL
eosinophil-derived	NULL
neurotoxin	NULL
.	NULL

J	NULL
Immunol	NULL
131:2977	NULL
,	NULL
1983	NULL
8	NULL
.	NULL

Dvorak	NULL
AM	NULL
,	NULL
Ackerman	NULL
SJ	NULL
,	NULL
Weller	NULL
PF	NULL
:	NULL
Subcellular	NULL
morphol-	NULL
3239	NULL
ogy	NULL
and	NULL
biochemistry	NULL
of	NULL
eosinophils	NULL
,	NULL
in	NULL
Harris	NULL
JR	NULL
(	NULL
ed	NULL
)	NULL
:	NULL
Blood	NULL
Cell	NULL
Biochemistry	NULL
,	NULL
vol	NULL
2	NULL
.	NULL

London	NULL
,	NULL
UK	NULL
,	NULL
Plenum	NULL
,	NULL
1990	NULL
,	NULL
p	NULL
237	NULL
9	NULL
.	NULL

Rosenberg	NULL
HF	NULL
,	NULL
Tenen	NULL
DG	NULL
,	NULL
Ackerman	NULL
SJ	NULL
:	NULL
Molecular	NULL
cloning	NULL
of	NULL
the	NULL
human	NULL
eosinophil-derived	NULL
neurotoxin	NULL
:	NULL
A	NULL
member	NULL
of	NULL
the	NULL
ribonuclease	NULL
gene	NULL
family	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
86:4460	NULL
,	NULL
1989	NULL
10	NULL
.	NULL

Bodger	NULL
MP	NULL
,	NULL
Mounsey	NULL
GL	NULL
,	NULL
Nelson	NULL
J	NULL
,	NULL
Fitzgerald	NULL
PH	NULL
:	NULL
A	NULL
mono-clonal	NULL
antibody	NULL
reacting	NULL
with	NULL
human	NULL
basophils	NULL
.	NULL

Blood	NULL
69:1414	NULL
,	NULL
1987	NULL
11	NULL
.	NULL

Bodger	NULL
MP	NULL
,	NULL
Newton	NULL
LA	NULL
:	NULL
The	NULL
purification	NULL
of	NULL
human	NULL
basophils	NULL
:	NULL
Their	NULL
immunophenotype	NULL
and	NULL
cytochemistry	NULL
.	NULL

Br	NULL
J	NULL
Haematol	NULL
67:281	NULL
,	NULL
1987	NULL
12	NULL
.	NULL

Stain	NULL
C	NULL
,	NULL
Stockinger	NULL
H	NULL
,	NULL
Scharf	NULL
M	NULL
,	NULL
Jager	NULL
U	NULL
,	NULL
Gossinger	NULL
H	NULL
,	NULL
Lechner	NULL
K	NULL
,	NULL
Bettelheim	NULL
P	NULL
:	NULL
Human	NULL
blood	NULL
basophils	NULL
display	NULL
a	NULL
unique	NULL
phenotype	NULL
including	NULL
activation	NULL
linked	NULL
membrane	NULL
structures	NULL
.	NULL

Blood	NULL
70:1872	NULL
,	NULL
1987	NULL
13	NULL
.	NULL

Valent	NULL
P	NULL
,	NULL
Majdic	NULL
O	NULL
,	NULL
Maurer	NULL
D	NULL
,	NULL
Bodger	NULL
M	NULL
,	NULL
Muhm	NULL
M	NULL
,	NULL
Bettelheim	NULL
P	NULL
:	NULL
Further	NULL
characterization	NULL
of	NULL
surface	NULL
membrane	NULL
structures	NULL
expressed	NULL
on	NULL
human	NULL
basophils	NULL
and	NULL
mast	NULL
cells	NULL
.	NULL

Int	NULL
Arch	NULL
Allergy	NULL
Appl	NULL
Immunol	NULL
91:198	NULL
,	NULL
1990	NULL
14	NULL
.	NULL

Ackerman	NULL
SJ	NULL
,	NULL
Loegering	NULL
DA	NULL
,	NULL
Gleich	NULL
GJ	NULL
:	NULL
The	NULL
human	NULL
eosinophil	NULL
Charcot-Leyden	NULL
crystal	NULL
protein	NULL
:	NULL
Biochemical	NULL
characteristics	NULL
and	NULL
measurement	NULL
by	NULL
radioimmunoassay	NULL
.	NULL

J	NULL
Immunol	NULL
125:2118	NULL
,	NULL
1980	NULL
15	NULL
.	NULL

Weller	NULL
PF	NULL
,	NULL
Bach	NULL
DS	NULL
,	NULL
Austen	NULL
KF	NULL
:	NULL
Biochemical	NULL
characterization	NULL
of	NULL
human	NULL
eosinophil	NULL
Charcot-Leyden	NULL
crystal	NULL
protein	NULL
(	NULL
lyso-phospholipase	NULL
)	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
259:15100	NULL
,	NULL
1984	NULL
16	NULL
.	NULL

Dvorak	NULL
AM	NULL
,	NULL
Letourneau	NULL
L	NULL
,	NULL
Login	NULL
GR	NULL
,	NULL
Weller	NULL
PF	NULL
,	NULL
Ackerman	NULL
SJ	NULL
;	NULL
Ultrastructural	NULL
localization	NULL
of	NULL
the	NULL
Charcot-Leyden	NULL
crystal	NULL
protein	NULL
(	NULL
lysophospholipase	NULL
)	NULL
to	NULL
a	NULL
distinct	NULL
crystalloid-free	NULL
granule	NULL
population	NULL
in	NULL
mature	NULL
human	NULL
eosinophils	NULL
.	NULL

Blood	NULL
72	NULL
:	NULL
150	NULL
,	NULL
1988	NULL
17	NULL
.	NULL

Dvorak	NULL
AM	NULL
,	NULL
Ackerman	NULL
SJ	NULL
:	NULL
;	NULL
Ultrastructural	NULL
localization	NULL
of	NULL
the	NULL
Charcot-Leyden	NULL
crystal	NULL
protein	NULL
(	NULL
lysophospholipase	NULL
)	NULL
to	NULL
granules	NULL
and	NULL
intragranular	NULL
crystals	NULL
in	NULL
mature	NULL
human	NULL
basophils	NULL
.	NULL

Lab	NULL
Invest	NULL
60:557	NULL
,	NULL
1989	NULL
18	NULL
.	NULL

Ackerman	NULL
SJ	NULL
,	NULL
Weil	NULL
GJ	NULL
,	NULL
Gleich	NULL
GJ	NULL
:	NULL
Formation	NULL
of	NULL
Charcot-Leyden	NULL
crystals	NULL
by	NULL
human	NULL
basophils	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
155:1597	NULL
,	NULL
1982	NULL
19	NULL
.	NULL

Bazan	NULL
JF	NULL
:	NULL
Haemopoietic	NULL
receptors	NULL
and	NULL
helical	NULL
cytokines	NULL
.	NULL

Immunol	NULL
Today	NULL
11:350	NULL
,	NULL
1990	NULL
20	NULL
.	NULL

Silberstein	NULL
DS	NULL
,	NULL
David	NULL
JR	NULL
:	NULL
The	NULL
regulation	NULL
of	NULL
human	NULL
eosinophil	NULL
function	NULL
by	NULL
cytokines	NULL
.	NULL

Immunol	NULL
Today	NULL
8:380	NULL
,	NULL
1987	NULL
21	NULL
.	NULL

Yamaguchi	NULL
Y	NULL
,	NULL
Hayashi	NULL
Y	NULL
,	NULL
Sugama	NULL
Y	NULL
,	NULL
Miura	NULL
Y	NULL
,	NULL
Kasahara	NULL
T	NULL
,	NULL
Kitamura	NULL
S	NULL
,	NULL
Torisu	NULL
M	NULL
,	NULL
Mita	NULL
S	NULL
,	NULL
Tominaga	NULL
A	NULL
,	NULL
Takatsu	NULL
K	NULL
:	NULL
Highly	NULL
purified	NULL
murine	NULL
interleukin	NULL
5	NULL
(	NULL
IL-5	NULL
)	NULL
stimulates	NULL
eosinophil	NULL
function	NULL
and	NULL
prolongs	NULL
in	NULL
vitro	NULL
survival	NULL
.	NULL

IL-5	NULL
as	NULL
an	NULL
eosinophil	NULL
chemotactic	NULL
factor	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
167:1737	NULL
,	NULL
1988	NULL
22	NULL
.	NULL

Kitamura	NULL
T	NULL
,	NULL
Noriko	NULL
S	NULL
,	NULL
Arai	NULL
K-I	NULL
,	NULL
Miyajima	NULL
A	NULL
:	NULL
Expression	NULL
cloning	NULL
of	NULL
the	NULL
human	NULL
IL-3	NULL
receptor	NULL
cDNA	NULL
reveals	NULL
a	NULL
shared	NULL
beta	NULL
subunit	NULL
for	NULL
the	NULL
human	NULL
IL-3	NULL
and	NULL
GM-CSF	NULL
receptors	NULL
.	NULL

Cell	NULL
66:1	NULL
165	NULL
,	NULL
1991	NULL
23	NULL
.	NULL

Tavernier	NULL
J	NULL
,	NULL
Devos	NULL
R	NULL
,	NULL
Cornelis	NULL
S	NULL
,	NULL
Tuypens	NULL
T	NULL
,	NULL
Van	NULL
der	NULL
Heyden	NULL
J	NULL
,	NULL
Fiers	NULL
W	NULL
,	NULL
Plaetinck	NULL
G	NULL
:	NULL
A	NULL
human	NULL
high	NULL
affinity	NULL
interleukin-5	NULL
receptor	NULL
(	NULL
ILSR	NULL
)	NULL
is	NULL
composed	NULL
of	NULL
an	NULL
ILS-specific	NULL
alpha	NULL
chain	NULL
and	NULL
a	NULL
beta	NULL
chain	NULL
shared	NULL
with	NULL
the	NULL
receptor	NULL
for	NULL
GM-CSF	NULL
.	NULL

Cell	NULL
66:1	NULL
175	NULL
,	NULL
1991	NULL
24	NULL
.	NULL

Her	NULL
E	NULL
,	NULL
Frazer	NULL
J	NULL
,	NULL
Austen	NULL
KF	NULL
,	NULL
Owen	NULL
WF	NULL
:	NULL
Eosinophil	NULL
hema-topoietins	NULL
antagonize	NULL
the	NULL
programmed	NULL
cell	NULL
death	NULL
of	NULL
eosinophils	NULL
.	NULL

Cytokine	NULL
and	NULL
glucocorticoid	NULL
effects	NULL
on	NULL
eosinophils	NULL
maintained	NULL
by	NULL
endothelial	NULL
cell-conditioned	NULL
medium	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
88:1982	NULL
,	NULL
1991	NULL
25	NULL
.	NULL

Lopez	NULL
AF	NULL
,	NULL
Eglinton	NULL
JM	NULL
,	NULL
Lyons	NULL
AB	NULL
,	NULL
Tapley	NULL
PM	NULL
,	NULL
To	NULL
LB	NULL
,	NULL
Park	NULL
LS	NULL
,	NULL
Clark	NULL
SC	NULL
,	NULL
Vadas	NULL
MA	NULL
:	NULL
Human	NULL
interleukin-3	NULL
inhibits	NULL
the	NULL
binding	NULL
of	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
and	NULL
interleukin-5	NULL
to	NULL
basophils	NULL
and	NULL
strongly	NULL
enhances	NULL
their	NULL
functional	NULL
activity	NULL
.	NULL

J	NULL
Cell	NULL
Physiol	NULL
145:69	NULL
,	NULL
1990	NULL
26	NULL
.	NULL

Lopez	NULL
AF	NULL
,	NULL
Vadas	NULL
MA	NULL
,	NULL
Woodcock	NULL
JM	NULL
,	NULL
Milton	NULL
SE	NULL
,	NULL
Lewis	NULL
A	NULL
,	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

3240	NULL
Elliott	NULL
MJ	NULL
,	NULL
Gillis	NULL
D	NULL
,	NULL
Ireland	NULL
R	NULL
,	NULL
Olwell	NULL
E	NULL
,	NULL
Park	NULL
LS	NULL
:	NULL
Interleukin-5	NULL
,	NULL
interleukin-3	NULL
,	NULL
and	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
cross-compete	NULL
for	NULL
binding	NULL
to	NULL
cell	NULL
surface	NULL
receptors	NULL
on	NULL
human	NULL
eosinophils	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
266:24741	NULL
,	NULL
1991	NULL
27	NULL
.	NULL

Yamaguchi	NULL
Y	NULL
,	NULL
Suda	NULL
T	NULL
,	NULL
Suda	NULL
J	NULL
,	NULL
Eguchi	NULL
M	NULL
,	NULL
Miura	NULL
Y	NULL
,	NULL
Harada	NULL
N	NULL
,	NULL
Tominaga	NULL
A	NULL
,	NULL
Takatsu	NULL
K	NULL
:	NULL
Purified	NULL
interleukin	NULL
5	NULL
supports	NULL
the	NULL
terminal	NULL
differentiation	NULL
and	NULL
proliferation	NULL
of	NULL
murine	NULL
eosinophilic	NULL
precursors	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
167:43	NULL
,	NULL
1988	NULL
28	NULL
.	NULL

Dent	NULL
LA	NULL
,	NULL
Strath	NULL
M	NULL
,	NULL
Mellor	NULL
AL	NULL
,	NULL
Sanderson	NULL
CJ	NULL
:	NULL
Eosinophilia	NULL
in	NULL
transgenic	NULL
mice	NULL
expressing	NULL
interleukin	NULL
5	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
172:1425	NULL
,	NULL
1990	NULL
29	NULL
.	NULL

Tominaga	NULL
A	NULL
,	NULL
Takaki	NULL
S	NULL
,	NULL
Koyama	NULL
N	NULL
,	NULL
Katoh	NULL
S	NULL
,	NULL
Matsumoto	NULL
R	NULL
,	NULL
Migita	NULL
M	NULL
,	NULL
Hitoshi	NULL
Y	NULL
,	NULL
Yamaguchi	NULL
S	NULL
,	NULL
Kanai	NULL
Y	NULL
,	NULL
Miyazaki	NULL
J	NULL
,	NULL
Usuku	NULL
G	NULL
,	NULL
Yamamura	NULL
K	NULL
,	NULL
Takatsu	NULL
K	NULL
:	NULL
Transgenic	NULL
mice	NULL
expressing	NULL
a	NULL
B	NULL
cell	NULL
growth	NULL
and	NULL
differentiation	NULL
factor	NULL
gene	NULL
(	NULL
interleukin	NULL
5	NULL
)	NULL
develop	NULL
eosinophilia	NULL
and	NULL
autoantibody	NULL
production	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
173:429	NULL
,	NULL
1991	NULL
30	NULL
.	NULL

Saito	NULL
H	NULL
,	NULL
Hatake	NULL
K	NULL
,	NULL
Dvorak	NULL
A	NULL
,	NULL
Leiferman	NULL
K	NULL
,	NULL
Donnenberg	NULL
A	NULL
,	NULL
Arai	NULL
N	NULL
,	NULL
Ishizaka	NULL
K.	NULL
,	NULL
Ishizaka	NULL
T	NULL
:	NULL
Selective	NULL
differentiation	NULL
and	NULL
proliferation	NULL
of	NULL
hematopoietic	NULL
cells	NULL
induced	NULL
by	NULL
recombinant	NULL
human	NULL
in-terleukins	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
85:2288	NULL
,	NULL
1988	NULL
31	NULL
.	NULL

Valent	NULL
P	NULL
,	NULL
Schmidt	NULL
G	NULL
,	NULL
Besemer	NULL
J	NULL
,	NULL
Mayer	NULL
P	NULL
,	NULL
Zenke	NULL
G	NULL
,	NULL
Lich	NULL
]	NULL
E	NULL
,	NULL
Hinterberger	NULL
W	NULL
,	NULL
Lechner	NULL
K	NULL
,	NULL
Maurer	NULL
D	NULL
,	NULL
Bettelheim	NULL
P	NULL
:	NULL
Interleukin-3	NULL
is	NULL
a	NULL
differentiation	NULL
factor	NULL
for	NULL
human	NULL
basophils	NULL
.	NULL

Blood	NULL
73:1763	NULL
,	NULL
1989	NULL
32	NULL
.	NULL

Hutt-Taylor	NULL
SR	NULL
,	NULL
Harnish	NULL
D	NULL
,	NULL
Richardson	NULL
M	NULL
,	NULL
Ishizaka	NULL
T	NULL
,	NULL
Denburg	NULL
JA	NULL
:	NULL
Sodium	NULL
butyrate	NULL
and	NULL
a	NULL
T	NULL
lymphocyte	NULL
cell	NULL
line-derived	NULL
differentiation	NULL
factor	NULL
induce	NULL
basophilic	NULL
differentiation	NULL
of	NULL
the	NULL
human	NULL
promyelocytic	NULL
leukemia	NULL
cell	NULL
line	NULL
.	NULL

Blood	NULL
71:209	NULL
,	NULL
1988	NULL
33	NULL
.	NULL

Tomonaga	NULL
M	NULL
,	NULL
Gasson	NULL
JC	NULL
,	NULL
Quan	NULL
SG	NULL
,	NULL
Golde	NULL
DW	NULL
:	NULL
Establishment	NULL
of	NULL
eosinophilic	NULL
sublines	NULL
from	NULL
human	NULL
promyelocytic	NULL
leukemia	NULL
(	NULL
HL-60	NULL
)	NULL
cells	NULL
:	NULL
Demonstration	NULL
of	NULL
multipotentiality	NULL
and	NULL
single-lin-eage	NULL
commitment	NULL
of	NULL
HL-60	NULL
stem	NULL
cells	NULL
.	NULL

Blood	NULL
67:1433	NULL
,	NULL
1986	NULL
34	NULL
.	NULL

Fischkoff	NULL
SA	NULL
,	NULL
Pollak	NULL
A	NULL
,	NULL
Gleich	NULL
GJ	NULL
,	NULL
Testa	NULL
JR	NULL
,	NULL
Misawa	NULL
S	NULL
,	NULL
Reber	NULL
TJ	NULL
;	NULL
Eosinophilic	NULL
differentiation	NULL
of	NULL
the	NULL
human	NULL
promyelocytic	NULL
leukemia	NULL
cell	NULL
line	NULL
,	NULL
HL-60	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
160:179	NULL
,	NULL
1984	NULL
35	NULL
.	NULL

Fischkoff	NULL
SA	NULL
,	NULL
Brown	NULL
GE	NULL
,	NULL
Pollak	NULL
A	NULL
:	NULL
Synthesis	NULL
of	NULL
eosinophil-associated	NULL
enzymes	NULL
in	NULL
HL-60	NULL
promyelocytic	NULL
leukemia	NULL
cells	NULL
.	NULL

Blood	NULL
68:185	NULL
,	NULL
1986	NULL
36	NULL
.	NULL

Denburg	NULL
JA	NULL
,	NULL
Silver	NULL
JE	NULL
,	NULL
Abrams	NULL
JS	NULL
:	NULL
Interleukin-5	NULL
is	NULL
a	NULL
human	NULL
basophilopoietin	NULL
:	NULL
Induction	NULL
of	NULL
histamine	NULL
content	NULL
and	NULL
basophilic	NULL
differentiation	NULL
of	NULL
HL-60	NULL
cells	NULL
and	NULL
of	NULL
peripheral	NULL
blood	NULL
basophil-e0-sinophil	NULL
progenitors	NULL
.	NULL

Blood	NULL
77:1462	NULL
,	NULL
1991	NULL
37	NULL
.	NULL

Fischkoff	NULL
SA	NULL
:	NULL
Graded	NULL
increase	NULL
in	NULL
probability	NULL
of	NULL
eosinophilic	NULL
differentiation	NULL
of	NULL
HL-60	NULL
promyelocytic	NULL
leukemia	NULL
cells	NULL
induced	NULL
by	NULL
culture	NULL
under	NULL
alkaline	NULL
conditions	NULL
.	NULL

Leuk	NULL
Res	NULL
12:679	NULL
,	NULL
1988	NULL
38	NULL
.	NULL

Rosenberg	NULL
HF	NULL
,	NULL
Ackerman	NULL
SJ	NULL
,	NULL
Tenen	NULL
DG	NULL
:	NULL
Human	NULL
eosinophil	NULL
cationic	NULL
protein	NULL
.	NULL

Molecular	NULL
cloning	NULL
of	NULL
a	NULL
cytotoxin	NULL
and	NULL
hel-minthotoxin	NULL
with	NULL
ribonuclease	NULL
activity	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
170:163	NULL
,	NULL
1989	NULL
39	NULL
.	NULL

Ackerman	NULL
SJ	NULL
,	NULL
Corrette	NULL
SE	NULL
,	NULL
Rosenberg	NULL
HF	NULL
,	NULL
Bennett	NULL
JC	NULL
,	NULL
Mas-trianni	NULL
DM	NULL
,	NULL
Nicholson-Weller	NULL
A	NULL
,	NULL
Weller	NULL
PF	NULL
,	NULL
Chin	NULL
DT	NULL
,	NULL
Tenen	NULL
DG	NULL
:	NULL
Molecular	NULL
cloning	NULL
and	NULL
characterization	NULL
of	NULL
human	NULL
eosinophil	NULL
Charcot-Leyden	NULL
crystal	NULL
protein	NULL
(	NULL
lysophospholipase	NULL
)	NULL
:	NULL
Similarities	NULL
to	NULL
IgE-binding	NULL
proteins	NULL
and	NULL
the	NULL
S-type	NULL
animal	NULL
lectin	NULL
superfamily	NULL
.	NULL

J	NULL
Immunol	NULL
150:456	NULL
,	NULL
1993	NULL
40	NULL
.	NULL

Orkin	NULL
SH	NULL
:	NULL
Globin	NULL
gene	NULL
regulation	NULL
and	NULL
switching	NULL
:	NULL
Circa	NULL
1990	NULL
.	NULL

Cell	NULL
63:665	NULL
,	NULL
1990	NULL
41	NULL
.	NULL

Wall	NULL
L	NULL
,	NULL
deBoer	NULL
E	NULL
,	NULL
Grosveld	NULL
F	NULL
:	NULL
The	NULL
human	NULL
beta-globin	NULL
gene	NULL
3	NULL
'	NULL
enhancer	NULL
contains	NULL
multiple	NULL
binding	NULL
sites	NULL
for	NULL
an	NULL
erythroid-specific	NULL
protein	NULL
.	NULL

Genes	NULL
Dev	NULL
2:1089	NULL
,	NULL
1988	NULL
42	NULL
.	NULL

Plumb	NULL
MA	NULL
,	NULL
Lobanenkov	NULL
VV	NULL
,	NULL
Nicolas	NULL
RH	NULL
,	NULL
Wright	NULL
CA	NULL
,	NULL
Za-vou	NULL
S	NULL
,	NULL
Goodwin	NULL
GH	NULL
:	NULL
Characterisation	NULL
of	NULL
chicken	NULL
erythroid	NULL
nuclear	NULL
proteins	NULL
which	NULL
bind	NULL
to	NULL
the	NULL
nuclease	NULL
hypersensitive	NULL
regions	NULL
upstream	NULL
of	NULL
the	NULL
beta	NULL
A-	NULL
and	NULL
beta	NULL
H-globin	NULL
genes	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
14:7675	NULL
,	NULL
1986	NULL
ZON	NULL
ET	NULL
AL	NULL
43	NULL
.	NULL

Tsai	NULL
SF	NULL
,	NULL
Martin	NULL
DI	NULL
,	NULL
Zon	NULL
LI	NULL
,	NULL
D'Andrea	NULL
AD	NULL
,	NULL
Wong	NULL
GG	NULL
,	NULL
Orkin	NULL
SH	NULL
:	NULL
Cloning	NULL
of	NULL
cDNA	NULL
for	NULL
the	NULL
major	NULL
DNA-binding	NULL
protein	NULL
of	NULL
the	NULL
erythroid	NULL
lineage	NULL
through	NULL
expression	NULL
in	NULL
mammalian	NULL
cells	NULL
.	NULL

Nature	NULL
339:446	NULL
,	NULL
1989	NULL
44	NULL
.	NULL

Mignotte	NULL
V	NULL
,	NULL
Eleouet	NULL
JF	NULL
,	NULL
Raich	NULL
N	NULL
,	NULL
Romeo	NULL
PH	NULL
:	NULL
Cis-	NULL
and	NULL
trans-acting	NULL
elements	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
erythroid	NULL
promoter	NULL
of	NULL
the	NULL
human	NULL
porphobilinogen	NULL
deaminase	NULL
gene	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
86:6548	NULL
,	NULL
1989	NULL
45	NULL
.	NULL

Mignotte	NULL
V	NULL
,	NULL
Wall	NULL
L	NULL
,	NULL
deBoer	NULL
E	NULL
,	NULL
Grosveld	NULL
F	NULL
,	NULL
Romeo	NULL
PH	NULL
:	NULL
Two	NULL
tissue-specific	NULL
factors	NULL
bind	NULL
the	NULL
erythroid	NULL
promoter	NULL
of	NULL
the	NULL
human	NULL
porphobilinogen	NULL
deaminase	NULL
gene	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
17:37	NULL
,	NULL
1989	NULL
46	NULL
.	NULL

Trainor	NULL
CD	NULL
,	NULL
Engel	NULL
JD	NULL
:	NULL
Transcription	NULL
of	NULL
the	NULL
chicken	NULL
histone	NULL
H5	NULL
gene	NULL
is	NULL
mediated	NULL
by	NULL
distinct	NULL
tissue-specific	NULL
elements	NULL
within	NULL
the	NULL
promoter	NULL
and	NULL
the	NULL
3	NULL
enhancer	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
9:2228	NULL
,	NULL
1989	NULL
47	NULL
.	NULL

Zon	NULL
LI	NULL
,	NULL
Youssoufian	NULL
H	NULL
,	NULL
Mather	NULL
C	NULL
,	NULL
Lodish	NULL
H	NULL
,	NULL
Orkin	NULL
SH	NULL
:	NULL
Activation	NULL
of	NULL
the	NULL
erythropoietin	NULL
receptor	NULL
promoter	NULL
by	NULL
transcription	NULL
factor	NULL
GATA-L.	NULL
Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
88:10638	NULL
,	NULL
1991	NULL
48	NULL
.	NULL

Talbot	NULL
D	NULL
,	NULL
Philipsen	NULL
S	NULL
,	NULL
Fraser	NULL
P	NULL
,	NULL
Grosveld	NULL
F	NULL
:	NULL
Detailed	NULL
analysis	NULL
of	NULL
the	NULL
site	NULL
3	NULL
region	NULL
of	NULL
the	NULL
human	NULL
beta-globin	NULL
dominant	NULL
control	NULL
region	NULL
.	NULL

EMBO	NULL
J	NULL
9:2169	NULL
,	NULL
1990	NULL
49	NULL
.	NULL

Philipsen	NULL
S	NULL
,	NULL
Talbot	NULL
D	NULL
,	NULL
Fraser	NULL
P.	NULL
Grosveld	NULL
F	NULL
:	NULL
The	NULL
beta-globin	NULL
dominant	NULL
control	NULL
region	NULL
:	NULL
Hypersensitive	NULL
site	NULL
2	NULL
.	NULL

EMBO	NULL
J	NULL
9:2159	NULL
,	NULL
1990	NULL
50	NULL
.	NULL

Higgs	NULL
DR	NULL
,	NULL
Wood	NULL
WG	NULL
,	NULL
Jarman	NULL
AP	NULL
,	NULL
Sharpe	NULL
J	NULL
,	NULL
Lida	NULL
J	NULL
,	NULL
Pretor-ius	NULL
IM	NULL
,	NULL
Ayyub	NULL
H	NULL
:	NULL
A	NULL
major	NULL
positive	NULL
regulatory	NULL
region	NULL
located	NULL
far	NULL
upstream	NULL
of	NULL
the	NULL
human	NULL
alpha-globin	NULL
gene	NULL
locus	NULL
.	NULL

Genes	NULL
Dev	NULL
4:1	NULL
588	NULL
,	NULL
1990	NULL
51	NULL
.	NULL

Zon	NULL
LL	NULL
,	NULL
Tsai	NULL
SF	NULL
,	NULL
Burgess	NULL
S	NULL
,	NULL
Matsudaira	NULL
P	NULL
,	NULL
Bruns	NULL
GA	NULL
,	NULL
Orkin	NULL
SH	NULL
:	NULL
The	NULL
major	NULL
human	NULL
erythroid	NULL
DNA-binding	NULL
protein	NULL
(	NULL
GF-1	NULL
)	NULL
:	NULL
Primary	NULL
sequence	NULL
and	NULL
localization	NULL
of	NULL
the	NULL
gene	NULL
to	NULL
the	NULL
X	NULL
chromosome	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
87:668	NULL
,	NULL
1990	NULL
52	NULL
.	NULL

Evans	NULL
T	NULL
,	NULL
Felsenfeld	NULL
G	NULL
:	NULL
The	NULL
erythroid-specific	NULL
transcription	NULL
factor	NULL
Eryf	NULL
!	NULL

:	NULL
A	NULL
new	NULL
finger	NULL
protein	NULL
.	NULL

Cell	NULL
58:877	NULL
,	NULL
1989	NULL
53	NULL
.	NULL

Zon	NULL
LI	NULL
,	NULL
Mather	NULL
C	NULL
,	NULL
Burgess	NULL
S	NULL
,	NULL
Bolce	NULL
M	NULL
,	NULL
Harland	NULL
R	NULL
,	NULL
Orkin	NULL
SH	NULL
:	NULL
Expression	NULL
of	NULL
GATA-binding	NULL
proteins	NULL
during	NULL
embryonic	NULL
development	NULL
in	NULL
Xenopus	NULL
laevis	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
88:10642	NULL
,	NULL
1991	NULL
54	NULL
.	NULL

Pevny	NULL
L	NULL
,	NULL
Simon	NULL
MC	NULL
,	NULL
Robertson	NULL
E	NULL
,	NULL
Kiein	NULL
WH	NULL
,	NULL
Tsai	NULL
SF	NULL
,	NULL
D'Agati	NULL
V	NULL
,	NULL
Orkin	NULL
SH	NULL
,	NULL
Costantini	NULL
F	NULL
:	NULL
Erythroid	NULL
differentiation	NULL
in	NULL
chimaeric	NULL
mice	NULL
blocked	NULL
by	NULL
a	NULL
targeted	NULL
mutation	NULL
in	NULL
the	NULL
gene	NULL
for	NULL
transcription	NULL
factor	NULL
GATA-1	NULL
.	NULL

Nature	NULL
349:257	NULL
,	NULL
1991	NULL
55	NULL
.	NULL

Ho	NULL
IC	NULL
,	NULL
Vorhees	NULL
P	NULL
,	NULL
Marin	NULL
N	NULL
,	NULL
Oakley	NULL
BK	NULL
,	NULL
Tsai	NULL
SF	NULL
,	NULL
Orkin	NULL
SH	NULL
,	NULL
Leiden	NULL
JM	NULL
:	NULL
Human	NULL
GATA-3	NULL
:	NULL
A	NULL
lineage-restricted	NULL
transcription	NULL
factor	NULL
that	NULL
regulates	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
alpha	NULL
gene	NULL
.	NULL

EMBO	NULL
J	NULL
10:1187	NULL
,	NULL
1991	NULL
56	NULL
.	NULL

Joulin	NULL
V	NULL
,	NULL
Bories	NULL
D	NULL
,	NULL
Eleouet	NULL
JF	NULL
,	NULL
Labastie	NULL
MC	NULL
,	NULL
Chretien	NULL
S	NULL
,	NULL
Mattei	NULL
MG	NULL
,	NULL
Romeo	NULL
PH	NULL
:	NULL
A	NULL
T-cell	NULL
specific	NULL
TCR	NULL
delta	NULL
DNA	NULL
binding	NULL
protein	NULL
is	NULL
a	NULL
member	NULL
of	NULL
the	NULL
human	NULL
GATA	NULL
family	NULL
.	NULL

EMBO	NULL
J	NULL
10:1809	NULL
,	NULL
1991	NULL
57	NULL
.	NULL

Ko	NULL
LJ	NULL
,	NULL
Yamamoto	NULL
M	NULL
,	NULL
Leonard	NULL
MW	NULL
,	NULL
George	NULL
KM	NULL
,	NULL
Ting	NULL
P	NULL
,	NULL
Engel	NULL
JD	NULL
:	NULL
Murine	NULL
and	NULL
human	NULL
T-lymphocyte	NULL
GATA-3	NULL
factors	NULL
mediate	NULL
transcription	NULL
through	NULL
a	NULL
cis-regulatory	NULL
element	NULL
within	NULL
the	NULL
human	NULL
T-cell	NULL
receptor	NULL
delta	NULL
gene	NULL
enhancer	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
11:2778	NULL
,	NULL
1991	NULL
58	NULL
.	NULL

Yamamoto	NULL
M	NULL
,	NULL
Ko	NULL
LJ	NULL
,	NULL
Leonard	NULL
MW	NULL
,	NULL
Beug	NULL
H	NULL
,	NULL
Orkin	NULL
SH	NULL
,	NULL
Engel	NULL
JD	NULL
:	NULL
Activity	NULL
and	NULL
tissue-specific	NULL
expression	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
NF-E1	NULL
multigene	NULL
family	NULL
.	NULL

Genes	NULL
Dev	NULL
4:1650	NULL
,	NULL
1990	NULL
59	NULL
.	NULL

Zon	NULL
LI	NULL
,	NULL
Gurish	NULL
MF	NULL
,	NULL
Stevens	NULL
RL	NULL
,	NULL
Mather	NULL
C	NULL
,	NULL
Reynolds	NULL
D	NULL
,	NULL
Austen	NULL
KF	NULL
,	NULL
Orkin	NULL
SH	NULL
:	NULL
GATA-binding	NULL
transcription	NULL
factors	NULL
in	NULL
mast	NULL
cells	NULL
regulate	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
mast	NULL
cell	NULL
carboxypeptidase	NULL
A	NULL
gene	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
266:22948	NULL
,	NULL
1991	NULL
60	NULL
.	NULL

Romeo	NULL
PH	NULL
,	NULL
Prandini	NULL
MH	NULL
,	NULL
Joulin	NULL
V	NULL
,	NULL
Mignotte	NULL
V	NULL
,	NULL
Prenant	NULL
M	NULL
,	NULL
Vainchenker	NULL
W	NULL
,	NULL
Marguerie	NULL
G	NULL
,	NULL
Uzan	NULL
G	NULL
:	NULL
Megakaryocytic	NULL
and	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

MRNA	NULL
FOR	NULL
GATA-BINDING	NULL
PROTEINS	NULL
IN	NULL
EOSINPHILS	NULL
erythrocytic	NULL
lineages	NULL
share	NULL
specific	NULL
transcription	NULL
factors	NULL
.	NULL

Nature	NULL
3441447	NULL
,	NULL
1990	NULL
61	NULL
.	NULL

Martin	NULL
DL	NULL
,	NULL
Zon	NULL
LI	NULL
,	NULL
Mutter	NULL
G	NULL
,	NULL
Orkin	NULL
SH	NULL
:	NULL
Expression	NULL
of	NULL
an	NULL
erythroid	NULL
transcription	NULL
factor	NULL
in	NULL
megakaryocytic	NULL
and	NULL
mast	NULL
cell	NULL
lineages	NULL
.	NULL

Nature	NULL
344:444	NULL
,	NULL
1990	NULL
62	NULL
.	NULL

Chirgwin	NULL
JM	NULL
,	NULL
Przybyla	NULL
AE	NULL
,	NULL
MacDonald	NULL
RJ	NULL
,	NULL
Rutter	NULL
WJ	NULL
:	NULL
Isolation	NULL
of	NULL
biologically	NULL
active	NULL
ribonucleic	NULL
acid	NULL
from	NULL
sources	NULL
enriched	NULL
in	NULL
ribonuclease	NULL
.	NULL

Biochemistry	NULL
18:5294	NULL
,	NULL
1979	NULL
63	NULL
.	NULL

Dorfman	NULL
DM	NULL
,	NULL
Wilson	NULL
DB	NULL
,	NULL
Bruns	NULL
GAP	NULL
,	NULL
Orkin	NULL
SH	NULL
:	NULL
Human	NULL
transcription	NULL
factor	NULL
GATA-2	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
267:1279	NULL
,	NULL
1992	NULL
64	NULL
.	NULL

Spiegelman	NULL
BM	NULL
,	NULL
Frank	NULL
M	NULL
,	NULL
Green	NULL
H	NULL
:	NULL
Molecular	NULL
cloning	NULL
of	NULL
mRNA	NULL
from	NULL
3T3	NULL
adipocytes	NULL
.	NULL

Regulation	NULL
of	NULL
mRNA	NULL
content	NULL
for	NULL
glycerophosphate	NULL
dehydrogenase	NULL
and	NULL
other	NULL
differentiation-depen-dent	NULL
proteins	NULL
during	NULL
adipocyte	NULL
development	NULL
.	NULL

J	NULL
Biot	NULL
Chem	NULL
258:10083	NULL
,	NULL
1983	NULL
65	NULL
.	NULL

Toothaker	NULL
LE	NULL
,	NULL
Gonzalez	NULL
DA	NULL
,	NULL
Tung	NULL
N	NULL
,	NULL
Lemons	NULL
RS	NULL
,	NULL
Le	NULL
Beau	NULL
MM	NULL
,	NULL
Arnaout	NULL
MA	NULL
,	NULL
Clayton	NULL
LK	NULL
,	NULL
Tenen	NULL
DG	NULL
:	NULL
Cellular	NULL
myosin	NULL
heavy	NULL
chain	NULL
in	NULL
human	NULL
leukocytes	NULL
:	NULL
Isolation	NULL
of	NULL
5	NULL
cDNA	NULL
clones	NULL
,	NULL
characterization	NULL
of	NULL
the	NULL
protein	NULL
,	NULL
chromosomal	NULL
localization	NULL
,	NULL
and	NULL
upregulation	NULL
during	NULL
myeloid	NULL
differentiation	NULL
.	NULL

Blood	NULL
78:1826	NULL
,	NULL
1991	NULL
66	NULL
.	NULL

Arcari	NULL
P	NULL
,	NULL
Martinelli	NULL
R	NULL
,	NULL
Salvatore	NULL
F	NULL
:	NULL
The	NULL
complete	NULL
sequence	NULL
of	NULL
a	NULL
full	NULL
length	NULL
cDNA	NULL
for	NULL
human	NULL
liver	NULL
glyceraldehyde-3-phosphate	NULL
dehydrogenase	NULL
:	NULL
Evidence	NULL
for	NULL
multiple	NULL
mRNA	NULL
species	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
12:9	NULL
179	NULL
,	NULL
1984	NULL
67	NULL
.	NULL

Lee	NULL
M-E	NULL
,	NULL
Temizer	NULL
DH	NULL
,	NULL
Clifford	NULL
JA	NULL
,	NULL
Quertermous	NULL
T	NULL
:	NULL
Cloning	NULL
of	NULL
the	NULL
GATA-binding	NULL
protein	NULL
that	NULL
regulates	NULL
endothelin-1	NULL
gene	NULL
expression	NULL
in	NULL
endothelial	NULL
cells	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
266	NULL
:	NULL
16188	NULL
,	NULL
1991	NULL
68	NULL
.	NULL

Tsai	NULL
SF	NULL
,	NULL
Strauss	NULL
E	NULL
,	NULL
Orkin	NULL
SH	NULL
:	NULL
Functional	NULL
analysis	NULL
and	NULL
in	NULL
3241	NULL
vivo	NULL
footprinting	NULL
implicate	NULL
the	NULL
erythroid	NULL
transcription	NULL
factor	NULL
GATA-1	NULL
as	NULL
a	NULL
positive	NULL
regulator	NULL
of	NULL
its	NULL
own	NULL
promoter	NULL
.	NULL

Genes	NULL
Dev	NULL
5:919	NULL
,	NULL
1991	NULL
69	NULL
.	NULL

Yamaguchi	NULL
Y	NULL
,	NULL
Suda	NULL
T	NULL
,	NULL
Ohta	NULL
S	NULL
,	NULL
Tominaga	NULL
K	NULL
,	NULL
Miura	NULL
Y	NULL
,	NULL
Kasahara	NULL
T	NULL
:	NULL
Analysis	NULL
of	NULL
the	NULL
survival	NULL
of	NULL
mature	NULL
eosinophils	NULL
:	NULL
IL-5	NULL
prevents	NULL
apoptosis	NULL
in	NULL
mature	NULL
human	NULL
eosinophils	NULL
.	NULL

Blood	NULL
78:2542	NULL
,	NULL
1991	NULL
70	NULL
.	NULL

Owen	NULL
WF	NULL
,	NULL
Rothenberg	NULL
ME	NULL
,	NULL
Petersen	NULL
J	NULL
,	NULL
Weller	NULL
PF	NULL
,	NULL
Silberstein	NULL
D	NULL
,	NULL
Sheffer	NULL
AL	NULL
,	NULL
Stevens	NULL
RL	NULL
,	NULL
Soberman	NULL
RJ	NULL
,	NULL
Austen	NULL
KF	NULL
:	NULL
Interleukin	NULL
5	NULL
and	NULL
phenotypically	NULL
altered	NULL
eosinophils	NULL
in	NULL
the	NULL
blood	NULL
of	NULL
patients	NULL
with	NULL
the	NULL
idiopathic	NULL
hypereosinophilic	NULL
syndrome	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
170:343	NULL
,	NULL
1989	NULL
71	NULL
.	NULL

Plaetinck	NULL
G	NULL
,	NULL
Van	NULL
der	NULL
Heyden	NULL
J	NULL
,	NULL
Tavernier	NULL
J	NULL
,	NULL
Fache	NULL
I	NULL
,	NULL
Tuypens	NULL
T	NULL
,	NULL
Fischkoff	NULL
S	NULL
,	NULL
Fiers	NULL
W	NULL
,	NULL
Devos	NULL
R	NULL
:	NULL
Characterization	NULL
of	NULL
interleukin	NULL
5	NULL
receptors	NULL
on	NULL
eosinophilic	NULL
sublines	NULL
from	NULL
human	NULL
promyelocytic	NULL
leukemia	NULL
(	NULL
HL-60	NULL
)	NULL
cells	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
172:683	NULL
,	NULL
1990	NULL
72	NULL
.	NULL

Sposi	NULL
NM	NULL
,	NULL
Zon	NULL
LI	NULL
,	NULL
Care	NULL
A	NULL
,	NULL
Valtieri	NULL
M	NULL
,	NULL
Testa	NULL
U	NULL
,	NULL
Gabbianelli	NULL
M	NULL
,	NULL
Mariani	NULL
G	NULL
,	NULL
Bottero	NULL
L	NULL
,	NULL
Mather	NULL
C	NULL
,	NULL
Orkin	NULL
SH	NULL
,	NULL
Peshcle	NULL
C	NULL
:	NULL
Cell	NULL
cycle-dependent	NULL
initiation	NULL
and	NULL
lineage-dependent	NULL
abrogation	NULL
of	NULL
GATA-	NULL
!	NULL

1	NULL
expression	NULL
in	NULL
pure	NULL
differentiating	NULL
hematopoietic	NULL
progenitors	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
89:6353	NULL
,	NULL
1992	NULL
73	NULL
.	NULL

Barker	NULL
RL	NULL
,	NULL
Loegering	NULL
DA	NULL
,	NULL
Arakawa	NULL
KC	NULL
,	NULL
Pease	NULL
LR	NULL
,	NULL
Gleich	NULL
GJ	NULL
:	NULL
Cloning	NULL
and	NULL
sequence	NULL
analysis	NULL
of	NULL
the	NULL
human	NULL
gene	NULL
encoding	NULL
eosinophil	NULL
major	NULL
basic	NULL
protein	NULL
.	NULL

Gene	NULL
1990	NULL
74	NULL
.	NULL

Hamann	NULL
KJ	NULL
,	NULL
Ten	NULL
RM	NULL
,	NULL
Loegering	NULL
DA	NULL
,	NULL
Jenkins	NULL
RB	NULL
,	NULL
Heise	NULL
MT	NULL
,	NULL
Schad	NULL
CR	NULL
,	NULL
Pease	NULL
LR	NULL
,	NULL
Gleich	NULL
GJ	NULL
,	NULL
Barker	NULL
RL	NULL
:	NULL
Structure	NULL
and	NULL
chromosome	NULL
localization	NULL
of	NULL
the	NULL
human	NULL
eosinophil-derived	NULL
neurotoxin	NULL
and	NULL
eosinophil	NULL
cationic	NULL
protein	NULL
genes	NULL
:	NULL
Evidence	NULL
for	NULL
intronless	NULL
coding	NULL
sequences	NULL
in	NULL
the	NULL
ribonuclease	NULL
gene	NULL
superfamily	NULL
.	NULL

Genomics	NULL
7.535	NULL
,	NULL
1990	NULL
From	NULL
www	NULL
.	NULL

by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

®	NULL
blO	NULL
0d	NULL
1993	NULL
81	NULL
:	NULL
3234-3241	NULL
Expression	NULL
of	NULL
mRNA	NULL
for	NULL
the	NULL
GATA-binding	NULL
proteins	NULL
in	NULL
human	NULL
eosinophils	NULL
and	NULL
basophils	NULL
:	NULL
potential	NULL
role	NULL
in	NULL
gene	NULL
transcription	NULL
LI	NULL
Zon	NULL
,	NULL
¥	NULL
Yamaguchi	NULL
,	NULL
K	NULL
Yee	NULL
,	NULL
EA	NULL
Albee	NULL
,	NULL
A	NULL
Kimura	NULL
,	NULL
JC	NULL
Benneftt	NULL
,	NULL
SH	NULL
Orkin	NULL
and	NULL
SJ	NULL
Ackerman	NULL
ETY	NULL
Op	NULL
~	NULL
2	NULL
A	NULL
gs	NULL
%	NULL
,	NULL
'	NULL
.	NULL

:	NULL
e	NULL
@	NULL
.	NULL

2	NULL
(	NULL
f	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/content/81/12/3234.full.html	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
requests	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/misc/rights.xhtml	NULL
#	NULL
reprints	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/subscriptions/index.xhtml	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

